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ABSTRACT  
   
The popularization of energy drink use as a supplement to exercise is 
steadily increasing, especially among young adult males. However, the effects of 
energy drinks on muscular performance in young adults have yet to be clearly 
elucidated.  Eight male subjects (mean age: 23.3 ± 4.3 yrs, height: 181.0  ±  5.3 
cm, fat percent 17.8 ±  5.2%, and weight 85.3 ± 12.6 kg) completed this 
randomized double-blinded cross over study.  The purpose of this study was to 
determine differences in acute muscular strength and endurance and Profile of 
Mood States (POMS) scores between three treatments (RockStar, sugar-free 
RockStar, and sugar-free caffeine-free Placebo).  It was hypothesized that there 
would be no significant differences in acute peak torque and endurance of the 
knee extensors and flexors or on fatigue and vigor subscores from the POMS 
questionnaire.  Each man was tested randomly at least 1 week apart.  Diet and 
time of day were held constant across trials.  Peak torque of knee extensors and 
flexors at 60, 180, 240 degress/second and fatigue index and total work were 
calculated by performing 50 repetitions at 240 degrees/second.  Table A indicates 
no significant differences in peak torque, fatigue index, or total work measures or 
in subjective measures of fatigue or vigor from the POMS between the treatments.  
This study indicates that RockStar energy drinks have no acute ergogenic effects 
in young men performing isokinetic strength or endurance testing. 
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TABLE A- Abstract RockStar SF RockStar Placebo 
Peak torque 60°/s Flexors (N-
meters) 101 + 26 106 + 22 103 + 27 
Peak torque 60°/s Extensors (N-
meters) 187 + 64 182 + 48 169 + 53 
Fatigue Index Flexors (% decline)  53 + 7 49 + 10 47 + 9 
Fatigue Index Extensors (% 
decline)  44 + 14 45 + 11 45 + 17 
Total work Flexors (N-meters) 2286 + 499 2254 + 490 2312 + 403 
Total work Extensors (N-meters) 3552 + 606 3497 + 330 3591 + 559 
POMS Vigor - Fatigue 15 + 5 15 + 5 17 + 5 
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Chapter 1 
INTRODUCTION 
 Since the distribution of the first energy drink in 1997 (Red Bull), the 
consumption of energy drinks has consistently increased among young adults over 
the years (Malinauskas, Aeby, Overton, Carpenter-Aeby, & Barber-Heidal, 2007).  
The energy drink market has launched over 500 brands of energy drinks in less 
than 15 years all targeting adolescents and young adults (Reissig, Strain, & 
Griffiths, 2009).  Furthermore, there is a notable increase in the utilization of 
energy drinks as an ergogenic aid and supplement in physically active young 
adults, with only the multivitamin surpassing its popularity in use (Walsh, 
Gonzalez, Ratamess, Kang, & Hoffman, 2010).  In a survey conducted in 2004, 
approximately 73% of college athletes aged nineteen years and older reported the 
use of energy drinks as a supplement for physical activity with a 20% higher 
reported use in male athletes than in female athletes (Froiland, Koszewski, Hingst, 
& Kopecky, 2004).  
 The primary claims made by the energy drink companies are that these 
drinks will increase performance, decrease fatigue, and allow one to work harder 
(Ballard, Wellborn-Kim, & Clauson, 2010).  Red Bull’s  ubiquitous slogan “It 
gives you wings” refers to the claim that Red Bull was developed “for people 
who want to have a clear and focused mind, perform physically, are dynamic and 
performance-oriented whilst also balancing this with a fun and active lifestyle” 
(Red Bull Gmbh, 2012).  The notorious declaration, “Unleash the Beast”, by 
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Monster  energy drink is a motto that hypes up the extended statement that it 
“packs a vicious punch but has a smooth flavor you can really pound down” 
(Monster Energy Company, 2012).   Furthermore, RockStar asserts that it is the 
“world’s most powerful energy drink . . . scientifically formulated to provide an 
incredible energy boost for those who lead active and exhausting lifestyles-from 
athletes to rock stars” (ROCKSTAR, Inc., 2012).   Male athletes typically 
consume energy drinks to supplement their training to improve strength, power, 
agility, and speed; however, the effect of energy drinks on acute muscle strength 
and fatigue is unknown (Froiland et al., 2004).    
Various research studies have shown that the combination of caffeine with 
herbal and botanical compounds (thermogenic agents) found in energy drinks 
provides a reduction in fatigue, an improvement in mood, and an increase in 
concentration and alertness (Alford, Cox, & Wescott, 2001; Hoffman et al., 2009; 
Horne & Reyner, 2001; Mets et al., 2011; Rashti et al., 2009; Smit, Cotton, 
Hughes, & Rogers, 2004; Walsh et al., 2010).  However, among male 
strength/power athletes, an energy drink supplement ingested before a Wingate 
power test to measure anaerobic performance resulted in no observable difference 
compared to a placebo (Hoffman et al., 2009).  A meta-analysis of caffeine’s 
effects on both high-intensity and endurance exercise performance confirms that 
caffeine can significantly improve endurance exercise but does not result in 
significant improvements in performance at a high-intensity exercise performance 
(Doherty & Smith, 2004).  Thus, endurance performance, in contrast to anaerobic 
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type strength/power performance, has been shown to benefit from the use of 
caffeine as an ergogenic aid, the main active ingredient in energy drinks, over 
anaerobic exercise and strength/power tests (Walsh et al., 2010).   
In general, the research on the efficacy of energy drinks on enhancing 
muscular endurance is mixed.  For example, the few studies on   Red Bull have 
shown significant benefits in aerobic performance but no improvement in high-
intensity or muscular endurance types of exercise (Astorino et al., 2011; Ivy et al., 
2009).  However, sugar-free Red Bull  energy drink had no significant effect on 
high-intensity, time-to-exhaustion running tests compared to a placebo in young 
adults (Candow, Kleisinger, Grenier, & Dorsch, 2009).  Moreover, using the 
energy drink Celsius showed no significant benefit on measures of strength in 
sedentary men who were resistance trained for 10 weeks (Lockwood et al., 2010).   
In studies by Wilborn et al and Dalbo et al, an energy drink was shown to 
significantly increase resting energy expenditure (REE) (Dalbo, Roberts, Stout, & 
Kerksick, 2008; Wilborn et al., 2009).  This has been interpreted to suggest that 
energy drinks may have important acute effects on performance if used as a 
supplement prior to exercise.  For example, acute aerobic endurance exercise 
performance was shown to be significantly enhanced by the ingestion of an 
energy drink prior to a one hour cycling time trial done on competitive cyclists 
(Ivy et al., 2009).  Additionally, muscular endurance on bench press repetitions 
was positively improved by ingesting Red Bull prior to the test (Forbes, 
Candow, Little, Magnus, & Chilibeck, 2007).  Thus, the acute ingestion of an 
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energy drink prior to endurance performance may have an important ergogenic 
effect on muscular endurance measures.   
In summary, the effects of energy drink consumption on muscular 
performance in young adults have yet to be clearly defined.  Although the 18-35 
year old age group is the main consumer of energy drinks, there remains a scarce 
amount of research done on this topic   (Malinauskas et al., 2007).  No previous 
research was found in the literature that reported the effectiveness of an energy 
drink on muscular strength and endurance using isokinetic measures of 
performance.  Furthermore, carefully designed blinded crossover studies 
comparing different versions of energy drinks (sweetened versus sugar-free) with 
a similar looking and tasting caffeine-free, sugar-free placebo have not been 
conducted.   
The primary purpose of this double-blind, crossover study is to compare 
the acute differences in muscle strength and endurance between two types of   
RockStar energy drink (original and sugar-free) and a similarly flavored sugar-
free caffeine-free placebo on young adult males.  Secondarily, differences in 
measures of fatigue and vigor (measured subjectively with a Profile of Mood 
States questionnaire, (POMS)) will be assessed following ingestion of two types 
of RockStar energy drink (original and sugar-free) and a similarly flavored 
sugar-free caffeine-free placebo.   
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It is hypothesized that there will be no significant differences between 
RockStar energy drink and a similarly flavored sugar-free caffeine-free placebo 
on acute muscle strength and endurance measured on an isokinetic dynamometer 
or on fatigue and vigor subscores from the POMS questionnaire.   
A primary specific aim is to test the difference between two versions of 
RockStar energy drink (original and sugar-free) and the placebo on acute peak 
torque of the hamstrings and quadriceps extension and flexion at three different 
speeds (240 degrees/second, 180 degrees/second, and 60 degrees/second), total 
work of the hamstrings and quadriceps muscles during a 50 repetition test at 240 
degrees/second, and fatigue index measures of hamstrings and quadriceps 
extension and flexion during 50 repetitions at 240 degrees/second utilizing a knee 
extension and flexion series. 
A secondary specific aim is to test the difference between two versions of 
RockStar  energy drink (original and sugar-free) and the placebo on acute post-
consumption fatigue and vigor subscores from a POMS questionnaire.  
Definition of Terms 
Ergogenic:  The ability to enhance physical performance and endurance. 
Fatigue Index:  The decline in peak torque during an endurance test expressed as a 
percentage (Hillery, 2010).  Also, this can be referred to as “the rate at which a 
person fatigues during muscular work” (Kannus, 1994).    
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Isokinetic Dynamometer:  A machine that measures performance in muscles 
through the application of isokinetic resistance (HUMAC NORM) (Hillery, 
2010).  
Peak Torque: Is the result of a maximal muscular contraction as the limb travels 
through a range of motion, reported as the “single highest” torque produced at that 
joint measured in Newton-meters (Kannus, 1994).  
Thermogenic Agents:  Chemicals that have been shown to increase REE and 
resting metabolic rate (RMR). 
Total Work: The sum of the work performed throughout the endurance test 
measured in Newton-meters (HUMAC NORM) (Hillery, 2010).       
Limitations 
 A primary limitation of this study will be the likely consumption of 
caffeine, outside the scope of this experiment.  Several food and drink products 
contain caffeine, such as chocolate and tea, which may introduce some 
confounding variables in our results.  In addition to this particular limitation, 
consumption of food and drinks before arrival at the laboratory in opposition to 
the regulations set by the researchers will negatively affect body composition 
measurements and may also have an additional affect on the results of muscular 
testing due to buffering of the energy drink.  Another limitation is the difference 
in body weight and height from subject to subject since the quantity of energy 
drink consumed will be constant for all subjects, thus, the amount of caffeine or 
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glucose per kilogram of body weight may affect each male differently.  For 
subjects who have previously consumed this specific brand of energy drink, the 
usefulness of a double-blind experiment may be diminished considering these 
males might be able to deduce which treatment they are drinking from visit to 
visit because of the distinct flavor of the energy drink.  Additionally, asking each 
male to self-report their daily beverage consumption to ascertain an average value 
of caffeine ingested each day will introduce some error in determining this value.  
Lastly, if a subject experiences any muscular strains or sprains at some point 
during this study, he will be evaluated to see if this issue is due to the isokinetic 
machine or is completely separate with the strain/sprain occurring in the upper 
body.  If this issue will have an effect on testing, the subject will be dropped from 
the study.     
Delimitations 
 There are several delimitations of this study.  A primary delimitation is the 
choice of energy drink.  In this study, only RockStar  energy drink (original and 
sugar-free flavors) will be used as experimental treatments.  This energy drink 
type and flavor was chosen because it is one of the top five energy drinks on the 
market, preceded only by Red Bull  and Monster (Ballard et al., 2010).  Also, 
the study will be delimited to only males, ages 18-30 years old.  This is the age 
group that is the main marketing target for energy drink campaigns (Reissig et al., 
2009).  Recruiting efforts will be delimited to ASU students, local gym-goers, and 
local firefighters.  Muscular strength, endurance and fatigue will be delimited to 
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measuring peak torque of the hamstrings and quadriceps muscles with flexion and 
extension of the knee using an isokinetic dynamometer.  Subjective measures of 
feelings of vigor and fatigue will be assessed with the Profile of Mood States 
questionnaire instead of a variety of questionnaires and surveys.      
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Chapter 2 
REVIEW OF LITERATURE 
Energy Drinks 
 Red Bull, Monster, RockStar, Nos, AMP, and Full Throttle are 
just a few of the names you will see plastered across aluminum cans containing 
what is commonly recognized as energy drinks.  Since Red Bull’s introduction 
to the beverage market in 1997, there has been an explosion of over 500 new 
energy drinks flooding the beverage aisle shelves, launching the energy drink 
market, which immediately began targeting adolescents and young adults (Reissig 
et al., 2009).  Numerous brands have been developed followed by a boom in sales, 
most notably among the adolescent and young adult customers (Arria et al., 2010; 
Ballard et al., 2010; Duchan, Patel, & Feucht, 2010; Lockwood et al., 2010; 
Malinauskas et al., 2007; Walsh et al., 2010).  Current sales exceed $9 billion, 
affirming that the energy drink market is a powerhouse that will remain strong for 
years to come; especially considering the largest consumer category is made up of 
the targeted population (Lockwood et al., 2010).  According to a survey of 
consumption patterns conducted at a state university, college students in the 18-35 
year old age group are the main consumers of energy drinks (Malinauskas et al., 
2007).   
Marketing strategies of these energy drink brands have been relentless in 
targeting the young adult population, with a shift towards the physically active 
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subpopulation in this age group by claiming consumption of their particular 
energy drink will increase energy expenditure and reaction speed, enhance 
concentration, and boost physical endurance (Ballard et al., 2010).  With slogans 
such as “It Gives You Wings” by Red Bull, “Unleash the Beast” by Monster, 
and “formulated to provide an incredible energy boost for those who lead active 
and exhausting lifestyles- from athletes to rock stars” by RockStar, one can see 
how these beverages can appeal to the often sleep-deprived, over-committed, 
sports-playing, super competitive, hard-driving group of young adults that are 
college students (Red Bull Gmbh, 2012; Monster Energy Company, 2012; 
ROCKSTAR, Inc., 2012).  The appeal of these slogans has apparently been 
effective in connecting to the college student population since there is a 
significantly increasing number of consumers among this group with more than 
half reporting energy drink use at least once a month (Arria et al., 2010; Duchan 
et al., 2010; Lockwood et al., 2010). A notable increase in the utilization of 
energy drinks has been demonstrated among physically active young adults as a 
supplement to exercise and physical activity (Walsh et al., 2010).  In a survey 
conducted at a Division I University among varsity athletes across a variety of 
sports, Froiland et al reported that approximately 73% of college athletes reported 
utilizing energy drinks as a supplement for improving their exercise performance 
(Froiland et al., 2004).  Male athletes reported their rationale for consuming 
energy drinks in this manner was to improve speed, agility, strength, and power 
(Froiland et al., 2004).   
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Energy drinks have been touted as having a mix of ingredients that 
provide ergogenic benefits when consumed before a workout; however, there is 
no conclusive evidence to support this claim.  Energy drinks typically contain 
caffeine, taurine, sugar, guarana, ginseng, B vitamins, ginko biloba, and carnitine 
(Malinauskas et al., 2007).  Table 1 (A and B) located in Appendix R indicates the 
ingredients in Original RockStar® and sugar-free RockStar®, respectively.   
Caffeine 
The main ingredient in every energy drink is caffeine (Ballard et al., 2010; 
Duchan et al., 2010; Forbes et al., 2007; Horne & Reyner, 2001; Ivy et al., 2009; 
Ragsdale et al., 2010).  An energy drink can contain the caffeine equivalent of 
two 12oz sodas (caffeinated) or five ounces of coffee which can contain a range 
of 30mg to 115mg caffeine per 12oz soda or cup of coffee (Chou & Benowitz, 
1994; Malinauskas et al., 2007).  A typical range for caffeine content is 80 to over 
500 mg per shot, bottle, or can, which can come in a variety of sizes including 1 
to 2.5 oz, 8 oz, 16 oz, and a jumbo sized 24 oz (Duchan et al., 2010).  RockStar® 
energy drink is now one of the most popular brands on the market with only Red 
Bulland Monster® as major competition.  
 Depending on the size and weight of the individual drinking this 
beverage, 160 mg of caffeine can provide a range of 1.7 to 3.5mg/kg caffeine per 
body weight for persons weighing between 200 to 100 pounds, respectively.  
These doses are within the low to moderate range (3 to 10 mg/kg) for safe 
caffeine administration and are considered nontoxic (Doherty & Smith, 2004).   
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While considered a “safe” amount of caffeine per kg of body weight, this amount 
has been demonstrated to provide some ergogenic benefit in improving exercise 
performance (Doherty & Smith, 2004).  However, in actual practice, young adult 
users such as college students often combine energy drinks with ingesting 
caffeine from many sources such as soft drinks, chocolate, and analgesics (Chou 
& Benowitz, 1994).  This mixed consumption of energy drinks with other forms 
of caffeine can easily lead to caffeine toxicity (Arria & O'Brien, 2011; Ballard et 
al., 2010; Chou & Benowitz, 1994; Malinauskas et al., 2007; O'Brien, McCoy, 
Rhodes, Wagoner, & Wolfson, 2008; Reissig et al., 2009).  High caffeine intake is 
known to lead to adverse reactions such as nausea, increased blood pressure and 
heart rate, and dehydration (Arria et al., 2010; Ballard et al., 2010; Candow et al., 
2009; Lockwood et al., 2010; Malinauskas et al., 2007; Maughan, Depiesse, 
Geyer, & International Association of Athletics, 2007; Ragsdale et al., 2010; 
Reissig et al., 2009; Thombs et al., 2010; Walsh et al., 2010), however values less 
than 500 mg/day have not been associated with increased risk for heart disease or 
dehydration (Popkin, AJCN, 2006). 
Table 2: Caffeine Content in Most Popular Energy Drinks 
 
Brand   Amount of Caffeine   
Serving Size in Ounces 
Per Milliliter 
RockStar   80 mg     8/240     
Amp   71 mg     8/240     
Full Throttle 70.5 mg     8/240     
Red Bull   80 mg     8.4/250     
Monster   80 mg     8/240     
* Values Provided by Ballard et al.  
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 Generally, caffeine is considered in the form of the coffee bean (Coffea 
Arabica), however,  it is also a naturally occurring substance in several plant 
species, seeds, and fruits that can be found in several foods but is primarily 
consumed in the form of colas, coffee, and tea (Desbrow & Leveritt, 2006; 
Duchan et al., 2010).  Caffeine’s extreme popularity as a stimulant, whether in its 
naturally occurring form in food and drink products or as a chemical additive, 
stems from its ease of use, widespread availability, and rapid half life (Doherty & 
Smith, 2004). Caffeine’s lipid soluble properties allow it to be rapidly absorbed 
and its affinity to bind to protein quickly distributes this purine throughout the 
body with effects taking place within 15-45 minutes after oral ingestion, though 
one hour is necessary for caffeine to reach its peak plasma concentration (Duchan 
et al., 2010).  There are several proposed mechanisms on how caffeine achieves 
physiological and mental adaptations to benefit an individual.  Because caffeine 
has been shown to improve endurance exercise, subjective mood, and may 
influence high intensity exercise performance, it is likely that it has more than one 
mechanism of action (Doherty & Smith, 2004).   
 Most commonly, it is thought that caffeine acts as a stimulant of the 
central nervous system (CNS) by blocking adenosine receptors leading to an 
increase in CNS activation and plasma epinephrine concentration (Addicott et al., 
2009; Alford et al., 2001; Ballard et al., 2010; Candow et al., 2009; Forbes et al., 
2007; Hoffman et al., 2009; Horne & Reyner, 2001; Maughan et al., 2007; 
Ragsdale et al., 2010; Thombs et al., 2010).  Antagonism of the CNS adenosine 
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receptors is successful in inhibiting adenosine from binding to its receptors and 
acting as an extracellular signaling molecule which attenuates the potency of 
adenosine as a sleep promoter (Addicott et al., 2009; Doherty & Smith, 2004).  In 
addition to increasing CNS activity, caffeine’s antagonistic effects are far 
reaching by also increasing blood pressure, metabolic rate, lipolysis, and mildly 
dilating the blood vessels (Smit et al., 2004).  The combination of these effects 
leads to a delay in fatigue, decreased pain perception, and improved mental 
alertness, concentration, and reaction time (Addicott et al., 2009; Alford et al., 
2001; Ballard et al., 2010; Candow et al., 2009; Forbes et al., 2007; Hoffman et 
al., 2009; Horne & Reyner, 2001; Maughan et al., 2007; Ragsdale et al., 2010; 
Thombs et al., 2010). 
Another widely accepted mechanism of caffeine is its ability to increase 
intracellular calcium release and uptake in the sarcoplasmic reticulum (Ballard et 
al., 2010; Candow et al., 2009; Forbes et al., 2007; Hoffman et al., 2009).  
Skeletal muscle contraction depends on the availability of calcium and its release 
from the sarcoplasmic reticulum to trigger the first step in muscular contraction 
by binding to troponin and causing it to shift so the myosin cross bridges can 
attach to the actin molecule,  leading to contraction of the muscle (Powers).  
Caffeine provides an enhanced neuromuscular transmission during this skeletal 
muscle excitation-contraction coupling by causing an increased mobilization of 
calcium from the cells in the sarcoplasmic reticulum (Hoffman et al., 2009).  
15 
Attenuation of muscular fatigue is the result, effectively providing an enhanced 
experience during physical activity. 
Phosphodiesterase inhibition is a mechanism of caffeine that is also 
believed to attenuate muscle fatigue and extend physical activity duration.  
Phosphodiesterase is an enzyme responsible for decreasing the levels of 
circulating epinephrine by way of degrading cyclic AMP (cAMP) (Wilborn et al., 
2009).  Increases in cAMP facilitate free fatty acid oxidation leading to a shift in 
substrate metabolism that favors lipolysis (Ballard et al., 2010; Hoffman et al., 
2009; Maughan et al., 2007; Wilborn et al., 2009).  This shift towards greater 
lipolysis directly decreases glyocogen breakdown in the body, efficiently sparing 
it for muscle utilization (Ballard et al., 2010; Hoffman et al., 2009; Maughan et 
al., 2007; Wilborn et al., 2009).  In addition to the glycogen sparing properties of 
cAMP, an increased amount of this substance also improves an individual’s 
resting energy expenditure (REE) or metabolic rate (Ballard et al., 2010; Hoffman 
et al., 2009; Maughan et al., 2007; Wilborn et al., 2009).   
 There are additional mechanisms that are not as popular as the 
aforementioned ones; however they may play a role in caffeine’s effects on 
physical activity and performance.  First, it is believed that caffeine decreases the 
concentration of potassium levels in the plasma which causes an increased 
concentration of potassium in the cells.  During exercise, this combination of 
decreased plasma levels and increased intracellular levels may help the cell 
membrane preserve contractility (Forbes et al., 2007).  Secondly, caffeine may 
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lessen an individual’s rate of perceived exertion (RPE) through attenuation of 
muscle fatigue and increased metabolic rate (Ballard et al., 2010; Doherty & 
Smith, 2004).  Thirdly, a mechanism that needs more research is one that states 
that the origin of an increase in free amino acids in the cerebral cortex is caffeine 
(Horne & Reyner, 2001).  Lastly, caffeine is considered to have effects in the 
respiratory and pulmonary systems after exercise.  For example, in athletes who 
exercised in a simulated altitude at a sub-maximal effort, an increase in end tidal 
alveolar partial pressure of oxygen (pO2) was demonstrated as well as a higher 
saturation of arterial oxyhemoglobin (SaO2) (Ballard et al., 2010).  After an 
exercise bout causing bronchoconstriction, caffeine was shown to diminish the 
decrease in forced expiratory volume in one second (FEV1) (Ballard et al., 2010).  
In conclusion, caffeine ingestion has been proven to provide several ergogenic 
benefits. While many of its purported mechanisms of action are known, a full 
understanding of caffeine’s effects is still in the beginning stages of research.   
Taurine  
 The addition of taurine with caffeine in energy drinks amplifies the 
stimulant effect. Taurine is a sulfonic intracellular amino acid, inhibitory in 
nature, principally found in skeletal muscle and the myocardium (Duchan et al., 
2010; Forbes et al., 2007; Horne & Reyner, 2001).  This ingredient found in 
energy drinks has not been extensively studied and therefore its properties and 
mechanisms of action have not been conclusively identified (Walsh et al., 2010). 
In the human body, it is created from cysteine and methionine in the liver and 
17 
remains there to assist with bile acid conjugation, a necessary process for fat 
absorption (Duchan et al., 2010; Tamamoto, Schmidt, & Lee, 2010).  Taurine is 
thought to be an important functional amino acid in retinal development, 
osmoregulation, maintaining calcium stability in the cells, and in platelet 
aggregation (Duchan et al., 2010; Tamamoto et al., 2010).  Of greater interest, 
taurine is believed to have antioxidant properties and to improve CNS function 
(Duchan et al., 2010; Tamamoto et al., 2010).  In the myocardium, ischemic 
hearts are reperfused likely due to taurine’s mobilization of calcium stores 
(Ragsdale et al., 2010).  Additionally, stimulation of the sympathetic nervous 
system (SNS) is suppressed by taurine’s possible control of cyclic nucleotide 
levels in the cells of the heart (Ragsdale et al., 2010).  The management of 
contractile function in skeletal muscle may be the responsibility of taurine’s 
reaction to neuronal signaling (Ballard et al., 2010).  Furthermore, taurine is a 
supposed free radical scavenger that exhibits protective characteristics in response 
to exercise-induced cellular stress and DNA damage (Ballard et al., 2010; Forbes 
et al., 2007).   
Although taurine has just begun to become a topic of interest in the 
research arena, there are a few studies that have demonstrated its ergogenic 
effects.  When studied as the only substance in an experimental treatment given to 
sedentary young adult males, taurine was revealed to provide significant 
improvements in maximal workload and VO2max (Zhang et al., 2004). Taurine 
has also been shown to solely augment endurance performance (Forbes et al., 
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2007; Walsh et al., 2010).   Approximately a minimum of 90 minutes is needed 
for taurine to reach peak plasma concentrations with a decline seen in less than 
two hours, presenting a major drawback in using taurine as an ergogenic aid 
(Zhang et al., 2004).  Nonetheless, the synergistic effects of taurine in 
combination with caffeine are subjective elevations in energy, mood, alertness 
and concentration (Horne & Reyner, 2001; Ivy et al., 2009; Walsh et al., 2010).  
In Rockstar’s® formulation, there are 80 mg of caffeine and 1000 mg of taurine, 
with a lack of daily value percentages because they have not yet been established 
(ROCKSTAR, Inc., 2012).  
Guarana 
In addition to Taurine, another ingredient in RockStar that has ergogenic 
effects is guarana.  Guarana is formally known as Brazilian cocoa due to its origin 
of being derived from plants in Brazil (Duchan et al., 2010).  The seeds that are 
collected from these plants are named guarana seeds, usually possessing more 
than double the amount of caffeine levels found in coffee beans, which can be 
anywhere from 3.6% to 5.8% caffeine (Duchan et al., 2010).  The process to make 
these guarana seeds commercially usable is to first grind them up to be dissolved 
in either juice or water to create the consistency of a paste which can then be used 
as an additive in beverages (Duchan et al., 2010).  Although the guarana seed’s 
caffeine content is more than twice that of the caffeine found in coffee beans, the 
FDA has acknowledged it as a safe additive (Duchan et al., 2010).  Both versions 
of RockStar® contain 25 mg of guarana seed extract in their formulations in 
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combination with 80 mg of caffeine, thus it is fair to consider that 105 mg of 
caffeine is delivered for every 8 oz of RockStar® consumed by an individual 
(ROCKSTAR, Inc., 2012).  Because of this,  guarana can magnify the effects of 
caffeine leading to adverse affects and caffeine toxicity when combined with 
beverages already containing moderate to high levels of caffeine or when using a 
high dosage of this substance alone (Duchan et al., 2010).  Since guarana contains 
caffeine, it can be anticipated to have the primary effects of caffeine when 
consumed in an energy drink or in other beverages (Ballard et al., 2010; Duchan 
et al., 2010).   
Sugar 
 Sugar is a typical ingredient in all energy drinks, with the obvious 
exception of the sugar-free and carbohydrate-free versions.  The sugar is in 
various forms, such as high fructose corn syrup, glucose, and sucrose (Ballard et 
al., 2010; Duchan et al., 2010; Smit et al., 2004).  The original version of 
RockStar® is comprised of 31 grams of sugar per 8 fluid ounces, but because 
RockStar® is commonly available as a 16 ounce can, most people drink the whole 
can which results in a total of 62 grams of sugar (ROCKSTAR, Inc., 2012).  The 
official US guidelines recommends a maximum daily intake of 25-45 grams of 
added sugar or a range of 5 to 9 teaspoons depending on the individual’s activity 
level (Duchan et al., 2010; Johnson et al., 2009).  For an individual on a 2000 kcal 
diet, sugar should only constitute about five to eight percent of those total calories 
(Duchan et al., 2010).  Unfortunately, RockStar® and other energy drink brands 
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offer bottles or cans that are 16 to 24 fluid ounces, which is double and triple the 
normal serving size and thus can double and triple the recommended maximum 
daily intake of sugar (Duchan et al., 2010).  Table 3 indicates the percent of 
calories from sugar from several of the popular energy drinks.   
Table 3: Sugar Content in Most Popular Energy Drinks 
   
Brand   
Amount 
of Sugar   
Ratio Compared to 
Recommended Maximum Daily 
Intake 
RockStar   31 g   31/32      =    96.90% 
Amp   29 g   29/32     =    90.60% 
Full Throttle 28.5 g   28.5/32  =    89.10% 
Red Bull   27 g   27/32     =    84.40% 
Monster   27 g   27/32     =    84.40% 
      *Sugar Values provided by Ballard et al.  
 The addition of sugar to energy drinks is related to its energizing effects 
which are seen in carbohydrates, with even more emphasis on these effects in 
simple sugars (Smit et al., 2004).  According to Horne et al, the rapid yet short-
lived (approximately ten minutes) effect of glucose can produce an awakening 
effect on CNS activity (Horne & Reyner, 2001).  In opposition, Smit et al state 
five minutes post-consumption, there is a significant increase in plasma glucose 
levels that tend to reach maximal absorption at about 20 minutes post-
consumption and continue to stay at elevated levels in excess of 75 minutes (Smit 
et al., 2004).  Regardless of the specific time necessary for absorption and to 
reach peak plasma levels, the addition of sugar to energy drinks is distinguished 
as having a positive effect on physical performance (Ballard et al., 2010).  Of 
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greater significance regarding the use of energy drinks as a supplement for 
physical activity and performance is the theory that when combined with caffeine, 
carbohydrates (such as sugar) can cause the rate of re-synthesis of muscle 
glycogen to drastically go up during a very intense exercise session (Lockwood et 
al., 2010).  Also, glucose ingestion and its subsequent metabolic breakdown has 
been shown to improve neural and cognitive performance by altering substrate 
utilization (Alford et al., 2001).  The possibility of improving reaction time, 
performance on concentration tasks, and memory is part of the rationale behind 
putting sugar in energy drinks (Smit et al., 2004).  Furthermore, there seems to be 
a direct association between the difficulty or demand of an assignment or job and 
the effects glucose has on performance.  Thus, glucose tends to have increased 
positive effects as the difficulty of tasks increases (Smit et al., 2004).  Whether 
sugar plays a direct role in improving cognitive performance or physical 
performance, its mechanism in fueling energy production is a relevant 
justification for its presence in most energy drinks.   
 In response to the concern for the increase in obesity and growing health 
consciousness of today’s society, the makers of energy drinks have developed 
sugar-free and carbohydrate-free versions of their original beverages.  Most 
popular brands now have sugar-free and carbohydrate-free versions of their 
product (Ballard et al., 2010).  Unfortunately, the addition of sugar substitutes to 
energy drinks may pose additional problems.  In fact, some sugar substitutes may 
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increase the propensity for obesity and may increase the risks for certain types of 
disease (Mela, 1997; Whitehouse, Boullata, & McCauley, 2008).          
Ginseng 
 Ginseng is a widely recognized dietary supplement and common 
ingredient in many beverages.  Ginseng has been shown to exhibit antioxidant 
properties and may be of assistance in improving cognitive function and lessening 
certain health conditions like diabetes (Tamamoto et al., 2010).    In addition to 
these proposed antioxidant properties, ginseng may have the ability to reduce 
certain cancer risks, enliven mood and sexual function, and improve immune 
function when taken as a dietary supplement at a dose of 100 to 200 mg per day 
(Duchan et al., 2010).  
 Ginseng is available in two varieties, an American variety and an Asian 
variety, with the Asian variety (Panax ginseng) being the most commonly used 
(Duchan et al., 2010).  The pharmacologically active steroid-like compounds 
found in ginseng are ginsenosides which give ginseng its bitter taste (Duchan et 
al., 2010; Tamamoto et al., 2010).  Interestingly, the season the plant was 
harvested and the age of that plant can affect the actual contents, quality, and 
potency of ginseng due to its particular pattern of growth (Duchan at al., 2010).  
Thus it is often unknown what the actual potency of the ginseng is in a given 
product.  RockStar® energy drink contains 25 mg of panax ginseng extract which 
is considerably lower than the usual amount found in dietary supplements but is 
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comparable to the amount found in other energy drinks (Duchan et al., 2010; 
ROCKSTAR, Inc., 2012).  Although products state that they contain a certain 
amount of ginseng, such as RockStar®’s 25 mg, it is actually unknown what its 
potency is or if this is an accurate value.  As far as ginseng’s benefits as an 
ergogenic aid, there is no conclusive body of evidence stating that it improves 
performance (Ballard et al., 2010). 
B Vitamins 
 A combination of B vitamins can be found in just about every energy 
drink on the market.  RockStar® contains vitamins B2 (riboflavin), B3 (niacin), 
B5 (pantothenic acid), B6, and B12 (cyanocobalamin) in amounts varying from 2 
mcg to 20 mg (Ballard et al., 2010; ROCKSTAR, Inc., 2012).  B vitamins can be 
obtained from proteins, beans, leafy green vegetables, and peas in addition to 
cereals and breads that have added B vitamins to their product.  They are 
important in everyday bodily functions such as red blood cell formation and 
assisting the body in the process of absorbing, using, and making energy from 
ingested food (Selhub, Morris, Jacques, & Rosenberg, 2009).  A deficiency in B 
vitamins, such as B12 or B6, can lead to anemia (Morris, Jacques, Rosenberg, & 
Selhub, 2007; Selhub et al., 2009).  Moreover, insufficient plasma concentrations 
of vitamin B-12 are largely responsible for a rise in concentrations of the amino 
acid homocysteine, which can be neurotoxic at high levels with research 
demonstrating a direct association between these elevated levels and  dementia, 
Alzheimer’s Disease (van Uffelen, Hopman-Rock, Chin, & van Mechelen, 2005), 
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and cardiovascular risk (Albert et al., 2008; Kang et al., 2008; Riggs, Spiro, 
Tucker, & Rush, 1996).  According to Riggs et al, “high plasma homocysteine 
concentrations may be implicated in cognitive impairment because of the 
association between homocysteine and vascular pathology, or alternatively, as a 
marker of B vitamin insufficiency” (Riggs, Spiro, Tucker, & Rush, 1996).  B 
vitamin therapy has demonstrated reductions in plasma homocysteine 
concentrations, attenuating the risk factors for disease (House et al., 2010; van 
Uffelen et al., 2005).  In this way, B vitamin supplementation may augment 
cognitive functioning and therefore have the capability to improve focus and 
concentration (Mets et al., 2011).  Because of their role in energy production, 
when there is a deficiency of B vitamins followed by their restoration, facilitation 
of concentration and enhanced physical performance may be likely results (Alford 
et al., 2001).  Furthermore, those who are physically active may require a higher 
daily dose of B vitamins because the effects of exercise training stresses the 
metabolic pathways in which B vitamins are the limiting agents (Manore, 2000).  
Although they play an important role in metabolic homeostasis, B vitamins have 
minimal to no influence on bringing about an ergogenic effect during or after 
acute exercise (Candow et al., 2009; Forbes et al., 2007).   
L-Carnitine 
At a content of 25 mg per 8 fluid ounces in RockStar®, L-carnitine 
(levocarnitine) is an ingredient that is essential for energy metabolism within the 
cell (Malaguarnera et al., 2007).  It is mainly found in the myocardium and 
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skeletal muscle which are the most active metabolic tissues, with its greatest 
stores present within the skeletal muscle tissue at a content that constitutes greater 
than 95% of the available L-carnitine in the body (Malaguarnera et al., 2007; 
Stephens, Constantin-Teodosiu, & Greenhaff, 2007).  Synthesis of this free 
radical scavenger appears to be finalized primarily in the liver and the kidneys 
and exhibits vital capabilities such as playing a role in stabilizing cellular 
membranes, assisting with directing nuclear transcription, and metabolism of 
branched chain amino acids (Brass & Hiatt, 1994, 1998; Lango, Smolenski, 
Narkiewicz, Suchorzewska, & Lysiak-Szydlowska, 2001).  At the market, ample 
levels of L-carnitine can be found in beans and avocados; however, red meat 
tends to be the chief source of this molecule (Brass & Hiatt, 1994, 1998; Lango et 
al., 2001).  When used as a daily dietary supplement to maintain normal stores in 
the body, a minimum of 8 to 11 mg is necessary since L-carnitine levels typically 
drop during high intensity exercise due to the buildup of acylcarnitines, disturbing 
its homeostasis (Brass & Hiatt, 1994, 1998; Lango et al., 2001).  Disease states 
such as peripheral vascular disease and chronic renal failure are likely to benefit 
from L-carnitine supplementation, additionally, L-carnitine content is increased in 
the tissues leading to a restoration of losses during exercise and lessening the 
harsh effects displayed by occurrences of ischemic injury when supplementation 
is directed to the myocardium  (Brass & Hiatt, 1994, 1998; Malaguarnera et al., 
2007).  In cases of hyperinsulemia, L-carnitine infusion has been demonstrated to 
increase its content not only through the addition intravenously, but also through 
the effect it has on high concentrations of insulin to also increase the 
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bioavailability of L-carnitine within the body (Maughan et al., 2007).  A study of 
L-carnitine exhibited its characteristic as a shuttle in brain tissue that aids in 
acetylcholine (Ach) synthesis by assisting the translocation of acetyl groups into 
the cytosol (Malaguarnera et al., 2007).  The consequences of L-carnitine 
deficiency have been clearly defined as negatively impacting energy production 
through altering the necessary metabolic pathways (Lango et al., 2001; 
Malaguarnera et al., 2007).   L-carnitine is acknowledged for being a very 
important molecule in the oxidation of fatty acids.  The transport of activated fatty 
acid chains to the site of ß- oxidation within the mitochondrial matrix is made 
possible by L-carnitine’s function in facilitating their movement across the inner 
membrane of the mitochondria (Brass & Hiatt, 1994, 1998; Lango et al., 2001; 
Malaguarnera et al., 2007; Stephens et al., 2007).    
Therefore, it has been theorized that the rate of fatty acid oxidation may 
increase as a result of an increase in L-carnitine (Brass & Hiatt, 1994, 1998; 
Malaguarnera et al., 2007; Stephens et al., 2007).  This becomes relevant when 
considering L-carnitine’s use as an ergogenic aid with studies having mixed 
results as far as its effectiveness in exercise performance.  According to a few 
studies done on the effects of L-carnitine, some have revealed a benefit in 
increasing fat metabolism as well as enabling the body to recover from the 
stresses of exercise (Forbes et al., 2007).  A study of L-carnitine treatment in 
centenarians proved that the supplementation of L-carnitine significantly 
improved total muscle mass and total fat mass when compared to a placebo 
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(Malaguarnera et al., 2007).   In contrast, the majority of studies focusing efforts 
on this theory of beneficial effects have shown that L-carnitine does not 
significantly improve or enhance performance or fat metabolism (Forbes et al., 
2007).  In any case, the possibility that L-carnitine may pose benefits in exercise 
performance by increasing the rate of fatty acid oxidation, followed by a reduced 
rate of glucose oxidation, and thereby preserving muscle glycogen content which 
may attenuate muscle fatigue, are the reasons for its addition as an ingredient in 
energy drinks (Brass & Hiatt, 1994, 1998; Malaguarnera et al., 2007; Stephens et 
al., 2007).  
Bod Pod and Other Body Composition Methods 
 Only recently has the Bod Pod become a popular method of body 
composition measurement.  Introduced as a means of obtaining body fat percent 
in the 1990’s, the Bod Pod uses the concept of air displacement plethysmography 
to calculate a person’s body density and employs other mathematical equations in 
addition to a measured or a predicted thoracic gas volume to determine the final 
result of body fat percentage (Dempster & Aitkens, 1995; McCrory, Gomez, 
Bernauer, & Mole, 1995; McCrory, Mole, Gomez, Dewey, & Bernauer, 1998).  
Its validity and reliability have been the primary topic of numerous studies 
including two of the first research projects to examine the Bod Pod: Philip 
Dempster’s 1995 study “A New Air Displacement Method for the Determination 
of Human Body Composition” and Megan McCrory’s 1995 study “Evaluation of 
a New Air Displacement Plethysmograph for Measuring Human Body 
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Composition” (Dempster & Aitkens, 1995; McCrory et al., 1995).  The Bod Pod 
was created to be multi-functional for use in a variety of applications including 
clinical, sport, and research; practically designed to quickly test body fat in a 
matter of minutes for use in all populations (COSMED Pulmonary Function 
Equipment, 2012).  Furthermore, the Bod Pod was designed to be used frequently 
with considerations of safety and comfort for the client (COSMED Pulmonary 
Function Equipment, 2012). 
 Dempster’s research involved twenty repeated measurements on two 
separate days of an aluminum cylinder of known volume (50,039 ml) in addition 
to five complete series of six successive measurements of cubes of increasing 
known volumes to mimic the varying weights of the general population with a 
mean percent error of .02% and .01% respectively (Dempster & Aitkens, 1995).  
Following Dempster’s research, McCrory recruited sixty-eight adults “varying 
widely in age (range 20-56 yr), ethnicity, and fatness” to assess validity and used 
a subsample to assess “same-day test-retest reliability” as compared to hydrostatic 
weighing (McCrory et al., 1995).  Her results showed no significant differences 
between the Bod Pod and hydrostatic weighing, confirming that the Bod Pod is “a 
highly reliable and valid method for determining % FAT in adult humans” 
(McCrory et al., 1995).  As a follow up to McCrory’s first study, her second 
research project aimed to evaluate the accuracy of the Bod Pod’s predicted 
thoracic gas volume when compared to a measured quantity in a sample of fifty 
men and women between the ages of 18 and 56 years (McCrory et al., 1998).  
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Consequently, McCrory found no significant differences between measured and 
predicted thoracic gas volume (53.5ml ± 63.3ml, mean difference ± standard 
error) or between percent body fat measurements using the measured and 
predicted volumes (0.2 ± 0.2% body fat), concluding with her support in utilizing 
the predicted thoracic gas volume (McCrory et al., 1998).  Additionally, in an 
attempt to investigate the precision of estimated measurements of body density, 
fat mass, and fat-free mass as well as repeated measurements of body volume and 
body weight by the Bod Pod, Wells and Fuller recruited men, women, boys, and 
girls (Wells & Fuller, 2001).  They demonstrated “good precision” for the 
estimated values and “high” precision for the repeated measurements of body 
volume and body weight in adults and children (Wells & Fuller, 2001).  
Furthermore, “within- and between-laboratory precision in body volume (BV) 
measurements using air displacement plethysmography (ADP)” via the Bod Pod 
was analyzed by Collins et al in thirty healthy men and women between the ages 
of 10 to 48 years by requiring each subject to undergo two successive tests at two 
different laboratories while two volunteers completed 10 successive tests at both 
laboratories (A. L. Collins, Saunders, McCarthy, Williams, & Fuller, 2004).  The 
within-laboratory accuracy of body volume measurements was found to be 
“reasonably good” and is the preferred method “when assessing individuals on a 
longitudinal basis” (A. L. Collins et al., 2004).     
 There have been several research projects with the aim to judge the 
validity and reliability of the Bod Pod compared to other body composition 
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methods such as hydrostatic weighing (HW), bioelectrical impedance analysis 
(BIA), and Dual Energy X-Ray Absorptiometry (DEXA).  Firstly, researcher Dale 
Wagner compared the Bod Pod to hydrostatic weighing and found that the Bod 
Pod was superior in “same-day test-retest reliability” and has the “potential to 
reduce technician error” due to its ease and convenience (Wagner & Heyward, 
1999).  Additionally, Robert Biaggi and colleagues set out to compare the Bod 
Pod to hydrostatic weighing and bioelectrical impedance analysis in forty-seven 
healthy men and women, demonstrating no gender differences in body fat 
estimation and a significant correlation of percent body fat measurements by the 
Bod Pod with hydrostatic weighing and bioelectrical impedance analysis (Biaggi 
et al., 1999).  As confirmation, Vescovi et al found the Bod Pod to be “a highly 
reliable method and valid when compared to HW for a heterogenous sample of 
adults” among ninety-five subjects (Vescovi et al., 2001).  Furthermore, Dr. 
Maddalozzo and his collaborators compared the “concurrent validity” of body 
composition measurements in forty-three college-aged women completed by the 
Bod Pod and DEXA with both measurements completed within ten minutes of 
each other (Maddalozzo, Cardinal, & Snow, 2002).  Among 23.3% of the women, 
body fat measurements were matched by both methods, while the average 
standard errors for the Bod Pod and the DEXA were 1.1 and 0.8, respectively, 
leading to the conclusion that there is concurrent validity of both methods 
(Maddalozzo et al., 2002).  Finally, C. Nunez et al compared the Bod Pod to HW 
and DEXA in one hundred and twenty children and a group of adults with the 
following outcome statement, “the air displacement plethysmography system has 
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the potential of providing an accurate and practical method of quantifying body 
fat in children as it now does in adults” (Nunez et al., 1999).  Therefore, it is not 
surprising that a review of studies (published between December 1995 and 
August 2001) comparing the Bod Pod to other body composition techniques, 
shows that the Bod Pod agrees with HW “within 1% body fat (BF) for adults and 
children” and with DEXA “within 1% BF for adults and 2% BF for children” 
(Fields, Goran, & McCrory, 2002).      
   Young to middle-aged men have been the target of several studies 
evaluating the validity of body composition measurements by the Bod Pod.  To 
start, body fat percentage measurements completed by the Bod Pod were obtained 
from sixty-nine Division IA college football players by Collins et al with the end 
result that “assessment of %fat using the Bod Pod is reliable and requires minimal 
technical expertise; however, in this study of collegiate football players, %fat 
values were under predicted when compared to HW [and] DXA. . .” (M. A. 
Collins et al.,1999).   To oppose, Dixon and associates evaluated percent body fat 
in collegiate wrestlers as tested by Bod Pod, HW, BIA, and 3-site skinfolds (SF) 
with the finding of “no significant differences in body density or %BF estimated 
by [Bod Pod], SF, and HW” (Dixon, Deitrick, Pierce, Cutrufello, & Drapeau, 
2005).  A later study also using college-aged men, but not athletes, confirms 
Dixon’s finding by stating that the Bod Pod is a “valid laboratory method... to 
estimate %fat in college-age Caucasian men” (Moon et al., 2008).   
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Muscular Performance and Fuel Utilization 
 Muscular performance is based upon several factors.  During aerobic 
resistance type exercise, Helmhout et al found that a person who has a larger 
percentage of fast twitch (Type II) fibers in the muscle being tested will reach 
fatigue quickly (Helmhout et al., 2010).  A more biochemical approach to 
performance is that “pH regulation and lactate transport mechanisms may 
constitute performance-limiting factors during high-intensity exercise” 
(Messonnier, Kristensen, Juel, & Denis, 2007).  A study looking at the effects of 
high-intensity interval training in cyclists found that interval training attenuated 
glycogenolysis rates which facilitated a reduced accumulation of lactic acid due to 
the improved ability to oxidize pyruvate (Ziemann et al., 2011).  Another 
consideration is the biochemical processes at the muscle, in which research on 
endurance exercise demonstrates that this type of activity stimulates 
mitochondrial biogenesis and expression of the GLUT4 isoform of the glucose 
transporter in muscle (Baar et al., 2002).   Outside the muscle, the liver is the key 
organ that supplies glucose and controls glucose homeostasis, involving 
glycogenolysis and gluconeogenesis, which is extremely important during 
exercise when skeletal muscles need fuel for energy (Hoene et al., 2009; 
Wasserman & Cherrington, 1991).   
  It is common knowledge that “Fat and carbohydrate are the principle 
substrates that fuel aerobic ATP synthesis in human skeletal muscle” (van Loon, 
Greenhaff, Constantin-Teodosiu, Saris, & Wagenmakers, 2001).  Muscle fuel 
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substrate utilization during exercise depends upon the type and duration of 
exercise as well as the individual’s training status.  For example, Kiens et al found 
that trained individuals participating in submaximal exercise had lower 
respiratory quotient values than untrained individuals which is a sign of greater 
lipid oxidation and therefore higher rates of free fatty acid uptake (Kiens, Essen-
Gustavsson, Christensen, & Saltin, 1993).   Furthermore, van Loon’s research in 
exercise intensity and substrate utilization concluded “that both carbohydrate and 
fat oxidation rates increased proportionally as the exercise intensity was increased 
up to a workload of 55% [maximum work] . . . however, as exercise intensity was 
increased to 75% [maximum work], both muscle glycogen and plasma glucose 
oxidation rates markedly increased and fat oxidation rate markedly decreased” 
(van Loon et al., 2001).  This finding is confirmed in a study of healthy fasted 
males performing knee extensions at increasing intensities which also concluded 
that as exercise intensity increased, muscle glycogen breakdown and glucose 
uptake increased (Helge, Stallknecht, Richter, Galbo, & Kiens, 2007).  Clearly, as 
stated by Brooks and Mercier, “the pattern of substrate utilization in an individual 
at any point in time depends on the interaction between exercise intensity-induced 
responses (which increase CHO utilization) and endurance training-induced 
responses (which promote lipid oxidation)” (Brooks & Mercier, 1994).  In 
conclusion, training status, genetic composition of muscles and muscle groups, 
type and intensity of exercise, as well as overall health contribute to muscular 
performance.     
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Fatigue Definitions and Mechanisms 
 One universal definition of fatigue has not been established due to an 
overall absence of consensus among the scientific and research worlds (Aaronson 
et al., 1999).  This lack of a single definition has led to the use of several different 
definitions depending on the type of research being conducted.  One definition 
that attempts to connect the physiological effects of fatigue to the psychological is 
from Lou et al and articulates fatigue as “a decreased capacity for work and 
reduced work efficiency, usually accompanied by a feeling of weariness and 
tiredness. . . [that] can be acute and come on suddenly or chronic and persist” 
(Lou, Weiss, & Carter, 2010).  Lou and colleagues further describe fatigue as 
being “at least partially reversible and . . . typically associated with motor and 
cognitive impairment, with reduced motivation and desire to rest” (Lou et al., 
2010).  There are also definitions that attempt to describe the physiological aspect 
of fatigue.  For example, Messonier et al refer to fatigue as “the rapid decline in 
force development during intensive exercise,” whereas Aaronson et al define 
fatigue as “functional organ failure” (Aaronson et al., 1999; Messonnier et al., 
2007).  To further complicate matters, muscular fatigue has been identified as a 
complex mechanism involving several components which still has not been 
entirely elucidated (Artioli, Gualano, Smith, Stout, & Lancha, 2010).   Regardless 
of the abundance of definitions available, fatigue is commonly separated into two 
distinguishable mechanisms: central fatigue and peripheral fatigue (Aaronson et 
al., 1999).  
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  Central fatigue focuses on events that depend upon the central nervous 
system (CNS) that facilitate and affect fatigue.  To clearly illustrate, Lou et al 
defines central fatigue as engaging “all the [CNS] processes influencing excitation 
and activation of the upper motor neurons including motivational factors and 
integration of sensory information, the conduction along the pyramidal tract, 
activation of lower motor neurons in the anterior horn of the spinal cord, the 
signal transfer along the lower motor neuron, and across the neuromuscular 
junction” (Lou et al., 2010).    Usually when fatigue occurs, this is due to the 
“malfunction of the central nervous system (CNS), such as impaired transmission 
between the CNS and the peripheral nervous system or dysfunction of selected 
areas of the CNS such as the hypothalamic region” (Aaronson et al., 1999).  This 
type of fatigue is normally thought of as the culprit of “reduced force generation 
caused by events proximal to the neuromuscular junction” (Lou et al., 2010).  
 While central fatigue is used to explain fatigue as having a psychological 
etiology, peripheral fatigue is used to explain it as having a physical etiology 
(Aaronson et al., 1999).  Peripheral fatigue can be thought of as the breakdown of 
events at or ahead of the neuromuscular junction (Lou et al., 2010).  For instance, 
this physical description is said to include secondary dysfunction “such as 
impaired neuromuscular transmission at the motor-end plate” (Aaronson et al., 
1999).  Another event that is caused by peripheral fatigue is the diminished 
capacity of the muscle fibers to maintain conduction velocity (Lou et al., 2010). 
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 The mechanism of fatigue is a multidimensional process with varying 
ideas of the exact pathway that is responsible for this phenomenon.  Firstly, Lou 
et al explains the progression of recruitment in normal skeletal muscle contraction 
as beginning with “the nervous system . . . recruit[ing] the smaller motor neurons 
and motor units first, and then slowly build[ing] upon that as the force of 
contraction increases” (Lou et al., 2010).  The most commonly accepted 
mechanisms of fatigue are the decrease in cellular pH and the increase in lactate 
anion concentration in the cell which both lead to the impairment of the 
excitation-contraction coupling by lowering force activation which is stimulated 
by calcium and thus inhibiting the development of tension in the muscle (Artioli 
et al., 2010; Messonnier et al., 2007).  Fatigue is also thought to occur through 
“changes in intracellular pH [which] may also modify protein conformation, alter 
channel properties, and depress the activity of key enzymes in glycolysis, which 
reduce the rate of ATP resynthesis” (Messonnier et al., 2007).  Skeletal muscle 
cells have proton buffering mechanisms that help delay the onset of acidosis as 
well as methods that remove lactate to help slow its accumulation within the 
muscle cells that when combined protect the muscle against fatigue (Artioli, 
Messonnier).  Additionally, Messonnier et al point out that there is a third 
protective mechanism, “The high concentration of bicarbonate in the interstitial 
space provides the major buffering mechanism in the extracellular fluid for 
protons leaving the muscle cells” (Messonnier et al., 2007).  However, these 
cellular protections cannot prevent the inevitable onset of fatigue after numerous 
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repeated contractions which bring about failure of the central and peripheral 
systems.   
Subjective Measures of Fatigue 
 A subjective measure of fatigue determines a person’s perception of his or 
her amount of fatigue and perceived feelings of fatigue.  Several questionnaires 
have been established as reliable and valid ways to measure fatigue subjectively, 
relying on the “patient’s own interpretation of their symptoms” or self assessment 
(Aaronson et al., 1999; Lou et al., 2010).  The lack of a consensus for a definition 
of fatigue has led to the “absence of a gold standard” for measuring fatigue 
(Aaronson et al., 1999).   Among researchers, the most widely used questionnaires 
are the Multidimensional Fatigue Inventory (MFI), the Fatigue Severity Scale 
(FSS), the Piper Fatigue Scale (PFS), the Visual Analogue Scale for Fatigue 
(VAS-F), the Multidimensional Assessment of Fatigue (MAF), and the Profile of 
Mood States (POMS) (Aaronson et al., 1999; Lou et al., 2010).  In his research 
concerning neuromuscular disease, Lou et al utilized the MFI with the reason 
being that it is a “true multidimensional instrument that assesses the physical and 
mental aspects of fatigue independently” (Lou et al., 2010).  The revised version 
of the PFS, a questionnaire containing twenty-two items that are complemented 
by five open-ended questions, has been proven by Annuziata and his team to have 
high construct validity and internal consistency (Annunziata et al., 2010).  The 
VAS-F is a scale that has been validated, containing eighteen items with five 
directed at energy and thirteen directed at fatigue, and requires the individual to 
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answer according to how they feel at that moment (Aaronson et al., 1999). Taking 
into account the entire week prior to testing, the MAF is a two item scale that asks 
an individual to rate the “degree to which [he or she] has experienced fatigue” and 
“how severe that fatigue was” (Aaronson et al., 1999).  The MAF’s convergent 
validity has been established through correlations with the POMS fatigue subscale 
(Aaronson et al., 1999).  Lastly, the POMS questionnaire contains sixty-five items 
covering six subscales: depression, tension, anger, confusion, fatigue, and vigor 
and is a “well-established measure of mood disturbance [with] the fatigue and 
vigor subscales of the POMS [being] the standards that most developers use to 
establish criterion or concurrent validity of their scales” (Aaronson et al., 1999; 
Purvis, Gonsalves, & Deuster, 2010).         
 The POMS questionnaire is a sixty-five question scale with answer 
choices ranging from “not at all” to “extremely”, is very easy to administer, is 
valid in all ages beginning at 18 years old, and can be completed in about ten 
minutes (McNair, Lorr, & Droppelman, 1971).  According to Stephen Gibson of 
the National Ageing Research Institute in Victoria, Australia, the POMS is one of 
“the more comprehensive inventories [and] has become one of the most widely 
used” (Gibson, 1997).  Additionally, Gibson’s research utilizing the POMS in the 
elderly population established its reliability and validity in measuring mood state 
in older adults which supplemented the already “demonstrated validity of the 
POMS across the entire age spectrum” (Gibson, 1997).  As far as using the POMS 
in physical activity research, a search of the literature published between 1975 
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and 1990 turned up “over 74 studies using the POMS in exercise and sport 
settings” and this number increased to over 80 studies using the POMS from 1991 
to 1996 (Berger & Motl, 2000).  Furthermore, the POMS was used in seventeen 
French male soccer players from a professional team to test the hypothesis that 
mood affects performance and vice versa and accurately “reflected changes in 
specific mood states of the team” (Filaire, Bernain, Sagnol, & Lac, 2001).       
Objective Measures of Fatigue 
 An objective measure of fatigue is an actual value that is obtained through 
a method involving a test of muscular strength and/or endurance by measuring the 
contractions in the muscle.  Objective measures of muscle strength and endurance 
include the use of “maximal voluntary isometric contraction”, a one repetition 
maximum (1-RM) test, magnetic stimulation and twitch interpolation techniques, 
and isokinetic concentric and eccentric contractions (Candow & Chilibeck, 2005; 
Charteris, 1999; Chromiak et al., 2004; Gomes, Simao, Marques, Costa, & da 
Silva Novaes, 2011; Granacher, Wolf, Wehrle, Bridenbaugh, & Kressig, 2010; 
Lou et al., 2010; McCarthy, Callaghan, & Oldham, 2008; Robles et al., 2011).  
Each of these tests is very brief, taking only minutes to complete.   
 The first, maximal voluntary isometric contraction, uses a “continuous 
supramaximal force, with the muscle contracting until failure” to obtain a fatigue 
value (Lou et al., 2010).  For example, because muscle fatigue is portrayed as a 
reduction in muscle contractile properties, measurements during a maximal 
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voluntary isometric contraction focus on the percent change in the contractile 
speed before and after the voluntary contraction (Bigland-Ritchie, Johansson, 
Lippold, & Woods, 1983).  However, this test depends on the will of the subject 
and requires maximal tetanic nerve stimulation in the muscle to obtain maximal 
contractions during this test (Bigland-Ritchie et al., 1983).  So, a maximal 
voluntary isometric contraction alone cannot sufficiently measure objective 
fatigue of a muscle or muscle group without the use of nerve stimulation 
(Bigland-Ritchie et al., 1983).  Still, McCarthy et al have used a test of 60% of 
maximum isometric contraction to obtain peak torque measures in the quadriceps 
muscle group of knee osteoarthritis patients using a Biodex dynamometer with 
excellent reliability (ICC 0.84-0.91, SEM 9.2-11 Hz for all three heads of the 
quadriceps muscle (McCarthy et al., 2008).     
 The 1-RM is the highest amount of weight that can be lifted one time as a 
dynamic measurement (Hickson, Dvorak, Gorostiaga, Kurowski, & Foster, 1988; 
Howley, 2001; Levinger et al., 2009).  While this test is easy to administer and 
quick to complete, without the necessity of expensive laboratory equipment, it 
may only be a reliable measure of muscle strength in healthy young adults having 
normal joint stability (Levinger et al., 2009).  Another limitation of this type of 
test is its diminished accuracy in subjects who are inexperienced lifters compared 
to those who have experience in weight-lifting exercises (Gomes, Simao, 
Marques, Costa, & da Silva Novaes, 2011).  As a result, the 1-RM test is 
frequently used in weight-lifting studies involving young healthy men to 
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determine the power of a muscle or muscle group specifically using the bench 
press and leg press protocols, however, this type of test has been used in healthy 
older adult males as well (Candow & Chilibeck, 2005; Chromiak et al., 2004; 
Gomes et al., 2011).  For instance, to determine the effectiveness of a 10 week 
training program, forty-one adult males were asked to complete as many 
repetitions as possible at 85% of their 1-RM test for the bench press and the leg 
press as a measure of muscular endurance (Chromiak et al., 2004).  Although the 
1-RM is becoming more popular as a method for measuring strength, laboratory 
methods utilizing an isokinetic dynamometer are still preferred when accessible 
(Levinger et al., 2009).  
 Magnetic stimulation and twitch interpolation techniques typically use 
electrical stimulation “to the motor nerve during an isometric voluntary 
contraction” to estimate the highest force achievable by the muscle (Todd, Taylor, 
& Gandevia, 2003).  The rationale behind utilizing electrical stimulation stems 
from the inability of volitional muscle contractions to stimulate the nervous 
system to recruit 100% of the motor neurons and motor units in a particular 
muscle or muscle group (Lou, Weiss, & Carter, 2010).  In reality, the nervous 
system “will recruit the smaller motor neurons and motor units first, and then 
slowly build up on that as the force of contraction increases” under normal 
conditions of in vivo volitional muscle contractions (Lou et al., 2010).  
Consequently, Lou et al state that “assessing physical fatigue is challenging [thus] 
it is useful to use percutaneous nerve stimulation or transcranial magnetic 
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stimulation to help elicit the maximal muscle contraction”, however, the main 
disadvantage of this method is the non-physiological approach to motor unit 
recruitment (Lou et al., 2010).  Hence, using this method of muscle fatigue 
determination does not represent the normal conditions in which muscles contract 
and cannot be used to mimic the true physiology of muscular contraction.       
Isokinetic dynamometry 
 The most common measure to assess muscular endurance and fatigue 
utilizes a computerized isokinetic dynamometer, the procedures of which have 
been investigated in numerous populations with results demonstrating “good test-
retest reliability, as well as safety and accuracy” (Robles et al., 2011).   Isokinetic 
dynamometry refers to the “measurement of muscle force under conditions of 
constant velocity” (Osternig, 1986).  Moreover, it wasn’t until the late 1960s with 
the development of the Cybex I dynamometer that the term isokinetic was 
established (Rothstein, Lamb, & Mayhew, 1987).  This method of measuring 
fatigue has become popular mainly for its safety since a passive dynamometer is 
used which “may minimize the risk of muscular and joint strain” (Osternig, 1986).  
Isokinetic dynamometry has been used in a wide range of subjects with varying 
ages, weights, heights, training statuses, and muscle and joint injuries (Osternig, 
1986; Rothstein et al., 1987; Scudder, 1980; Siqueira, Pelegrini, Fontana, & 
Greve, 2002).   
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 According to a report defining reliability and validity, the test-retest 
reliability of an instrument can be characterized by the “consistency with which. . 
. . [the] individual’s scores remain relatively the same” using the same method at 
different times (Golafshani, 2003).  If the test-retest reliability of an instrument is 
high, the results are said to be repeatable (Golafshani, 2003).  Validity on the 
other hand “determines whether the research truly measures that which it was 
intended to measure or how truthful the research results are” (Golafshani, 2003).     
 As far as validity is concerned, peak torque as measured by an  isokinetic 
dynamometer has become the “gold standard and reference point in all isokinetic 
measurements against which accuracy, precision, and clinical relevance of all 
other parameters should be compared” (Kannus, 1994).  Likewise, Li’s reliability 
study using the Cybex 6000 on 18 males and 12 females with no previous knee 
injuries determined that the isokinetic dynamometer “shows high reliability in 
measuring isokinetic concentric and eccentric peak torque, total work, and 
average power of knee extensor and flexor muscle groups” with interclass 
correlation coefficients of 0.82-0.91 for peak torque, 0.76-0.89 for total work, and 
0.71-0.88 for average power (Li, Wu, Maffulli, Chan, & Chan, 1996).  High test-
retest reliability and validity of peak torque and work measures for knee flexion 
and extension were found in several research projects (Adsuar, Olivares, del 
Pozo-Cruz, Parraca, & Gusi, 2011; Feiring, Ellenbecker, & Derscheid, 1990; 
Flansbjer & Lexell, 2010; Sole, Hamren, Milosavljevic, Nicholson, & Sullivan, 
2007).     
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 Isokinetic dynamometry has been employed in hundreds of studies; 
however, the following highlights research specifically using the knee extension 
and flexion series in healthy adults.  A Biodex dynamometer was utilized to 
determine “isokinetic concentric strength (torque)” in knee extension and flexion 
in healthy men ages 18-76 years (Candow & Chilibeck, 2005).  Furthermore, 
Granacher and colleagues used isokinetic dynamometry to measure fatigue in gait 
patterns in the young and elderly with the knee flexion and extension protocol 
(Granacher et al., 2010).  To compare the influence of gender and age on peak 
torque values in 139 men and 141 women, all considered clinically healthy; the 
knee extension and flexion series of an isokinetic dynamometer was used with 
results showing influences from both gender and age (Borges, 1989).  Also, the 
Cybex 6000 isokinetic dynamometer accurately measured the peak torque of knee 
extension and flexion at several speeds in intercollegiate level athletes (Charteris, 
1999).  Another study utilizing isokinetic dynamometry in athletes is Potteiger et 
al’s research in division I hockey athletes, with a mean age of 20.7 years, to 
measure “force production in the quadriceps and hamstring muscles” (Potteiger, 
Smith, Maier, & Foster, 2010).  Lastly, the peak torque of Greek male rowers was 
assessed isokinetically at varying speeds to understand differences in strength and 
joint mobility in the hips, knees, and ankles (Riganas, Vrabas, Papaevangelou, & 
Mandroukas, 2010).  Therefore, the widespread use of isokinetic dynamometry 
for all ages, weights, and health statuses has been demonstrated.  Considering the 
different methods of objectively measuring fatigue, a safe and valid choice is the 
isokinetic dynamometer.               
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 It is obvious that measuring muscular fatigue is not a simple task.  No 
matter which method is utilized in research, each type of test has its limitations.  
Moreover, no single test can perfectly measure the maximal strength of a muscle 
or muscle group unless combined with some type of electrical stimulation which 
does not simulate normal conditions.  Therefore, it is necessary for researchers to 
pick the best method available considering the subjects and purpose of the study 
to be conducted.  In studies investigating power measures, the best test is a 1 RM 
because it simulates the dynamic movement utilized during power exercises.  
Furthermore, studies looking at muscle strength should employ an isokinetic 
dynamometer to obtain peak torque values because of its high test-retest 
reliability and validity.  Conversely, studies examining muscle endurance may 
acquire the best results from tests using isometric and isokinetic contractions to 
muscle failure.   But, if normal conditions are not a requirement of the methods of 
a study, the truest measure of muscle strength and fatigue can be achieved through 
the combination of electrical nerve stimulation and volitional maximal 
contractions.  Considering the numerous options for testing muscle strength, 
endurance, and fatigue, it is easy to recognize the complexity of the physiology 
behind muscular contraction.  Nonetheless, if research is attempting to mimic 
muscular contractions, strength, and fatigue as it occurs in the real world whether 
in gyms, parks, or during activities of daily living, it is the responsibility of the 
investigator to select the most appropriate test.               
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Chapter 3 
METHODS 
Study Design 
 This study utilized a double-blind, randomized, placebo-controlled, cross-
over research design.  The main purpose of the study was to determine the effect 
of RockStar® energy drinks (both original and sugar-free) compared to a similar 
tasting placebo on acute muscle strength and fatigue.  Secondarily, differences in 
subjective measures of fatigue and vigor were evaluated between the treatments. 
The hypothesis of this experiment was that there would be no significant 
difference in muscular strength or endurance between each RockStar® energy 
drink treatment and a similarly flavored sugar-free, caffeine-free placebo.  
Additionally it was hypothesized that there would be no significant differences in 
subjective measures of fatigue and vigor between the treatments.  
Subjects 
 Twenty healthy men between the ages of 18 and 30 years old and 
weighing 120-220 pounds were selected for this study.  All subjects were 
recruited from ASU campuses, local gyms/recreation centers, and local firefighter 
departments using flyers, email lists, and classroom visits.  This particular 
population was chosen due to the energy drink market targeting physically active 
young adult males in marketing and advertising strategies (Arria et al., 2010), 
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(Ballard et al., 2010), (Froiland et al., 2004), (Reissig et al., 2009), (Walsh et al., 
2010).  This study was approved by the Arizona State University Institutional 
Review Board and all subjects provided their informed consent prior to 
participation.   
Inclusion and Exclusion Criteria 
 To be included in the study, men needed to be aged 18-30 years old and 
weigh between 120-220 pounds. The age and weight requirements were to help 
minimize some of the variability of the effects of energy drinks on people of 
different size and weight.  Additionally, each subject was required to have 
abstained from energy drink consumption for two or more weeks prior to data 
collection and throughout the duration of the study.  Also, only subjects who 
reported that they exercised no more than three times per week were included to 
prevent any “currently training” athletes from participating in this study and to 
make this research more generalizable.  All subjects completed a Physical 
Activity Readiness Questionnaire (Par-Q), a medical history questionnaire, and a 
daily beverage consumption survey to determine eligibility for participation in 
this study.  Each subject was required to be absent of any respiratory, 
cardiovascular, and neurological diseases, and to verify that there was no history 
of psychological disorders, seizures, migraines, or stroke.  Also, any subjects with 
diabetes, abnormal blood pressure and heart rate, and/or who reported adverse 
reactions to caffeine were excluded from the study.  Subjects who reported having 
musculoskeletal issues, knee injuries, and/or a muscular pain or those who 
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currently use illegal drugs, smoke cigarettes or frequently consumed alcohol were 
excluded.   
 Prior to the start of testing, each subject was asked to report his daily 
beverage consumption to determine the average daily intake of caffeine.  Once 
testing began subjects were asked to refrain from caffeine ingestion at least 24 
hours prior to a testing session.  Subjects were given a list of caffeine containing 
foods and beverages and asked to refrain from any beverages, foods, dietary 
supplements, and /or analgesics containing caffeine (Addicott et al., 2009).  Each 
participant was asked to refrain from consuming any and all energy drinks for the 
duration of this study.  Subjects were asked to refrain from alcohol consumption 
and strenuous physical activity for at least 24 hours prior to testing sessions.  At 
the first session, subjects were asked to report what their dinner meal was the 
previous night and then they were asked to consume that same meal the night 
before every testing session for each of the testing periods of the study.  All 
subjects were instructed not to change their current diet (other than caffeine use) 
and physical activity.   
General Overview of Procedure 
 Subjects were asked to arrive at the laboratory in a fasted state with no 
consumption of food for at least 12 hours prior to testing, but well hydrated 
through the consumption of only water prior to each testing session.  Subjects 
came to the lab for four different occasions over the course of four to five weeks 
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(one treatment session every week). A model of the testing timeline and 
procedures are included in Appendix A.  Initial screening was done by email.  
Interested participants completed a brief online (Survey Monkey) questionnaire to 
determine eligibility.  If deemed eligible, subjects were scheduled for an initial 
session (Visit 1) to explain the study and obtain informed consent.  If subjects 
agreed to participate, then basic demographic and health history information and 
food and beverage consumption data were collected. Additionally, baseline values 
of weight and body composition were measured and subjects were provided 
familiarization with the isokinetic testing procedures. Visit 1 lasted about an hour 
and twenty minutes.  Prior to the remaining three visits (Visit 2, 3, and 4), 
subjects were randomly assigned to a treatment (either RockStar®, RS; Sugar- 
Free RockStar®, SFRS; or placebo, P) for each visit.  The remaining three visits 
were experimental.  The subjects were asked to arrive at the laboratory in a fasted 
state and to sit at a table to fill out a dinner survey.  The subject was then given a 
randomly chosen treatment (16 ounces in an opaque plastic cup) and allotted 10 
minutes to consume this drink.  The subject was then given 15 minutes to 
complete the POMS questionnaire before testing on the isokinetic machine 
commenced.  Each testing session was separated by no less than seven days to 
help ensure the appropriate amount of wash out time was given for any lasting 
effects from the energy drink.  Each subject was scheduled at a similar time for 
each visit.  Visits 2-4 required about one hour to 1hour and 15 minutes to 
complete.  Visit 4 also included a second Bod Pod measurement.   
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Randomization and Double-Blinding Methods 
 This study used a double-blind randomized cross-over design and utilized 
a familiarization trial, baseline measurements, and a similarly flavored sugar-free 
and caffeine-free placebo as controls.  Each participant received a randomly 
selected treatment for each of his three experimental visits (Visit 3, 4 and 5).  
Treatment order for each participant was randomly chosen using a block 
randomization process.  A chart outlining the randomization process for each 
subject is included in Appendix L.  The order for each participant was recorded 
on a number-coded data sheet that was kept in the room with the refrigerator and 
treatment preparation supplies.  The person preparing the drinks was given no 
identifiers of which letter corresponded to which treatment.  Also, all participants’ 
identifying information was excluded such that on each beverage cup only the 
participant i.d. number followed by three letters (A, B, and C) was provided.  
Each night, the PI prepared the placebo treatment and stored it in the refrigerator 
alongside the other two treatments; each treatment was clearly labeled with the 
name (Placebo, RockStar, and Sugar-Free RockStar) to prevent any errors.  
She also labeled the plastic cups with the appropriate number and letter for that 
particular visit (ex: 1B, 2A, etc).  The next morning, a co-investigator (not the PI) 
poured the appropriate treatment into the pre-labled cup.  The PI was completely 
blinded as was the participant to which treatment each person received.  She was 
not involved in the pouring or final preparation of the treatment and had no 
knowledge of which treatment the participant was consuming.   
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 Muscular strength and endurance testing was also randomized by leg.  For 
each test there were two identical pieces of paper with the letters R and L for right 
leg and left leg face-down on a table. The co-investigator (not the PI) randomly 
switched the papers face-down for the PI to select which leg was to be tested first.   
Treatments 
 The three treatments in this study are Original RockStar®, ORS; Sugar-
free RockStar®, SFRS; and a sugar-free caffeine-free placebo, Pl.  Each subject 
will be given a 16 oz. serving (equivalent of 1 can, 473 ml) of each treatment 
which will be presented in a red plastic cup.  The two RockStar  treatments were 
purchased commercially and poured into the cup immediately prior to 
consumption (RockStar  Energy Drink: ROCKSTAR, Inc., Las Vegas, NV 
89126).  The sugar-free version of RockStar  tastes very similar and has the 
same carbonation as the original version of RockStar  .  The placebo was a 
sugar-free, caffeine-free drink that was made in a laboratory in the nutrition 
department at the ASU Polytechnic campus.  It was tested and determined to 
closely replicate the effervescence, sweetness, tartness, and taste of the 
RockStar  energy drink.  The placebo was a created from a combination of 
Sierra Mist Free, Crystal Light Natural Cherry Pomegranate flavor, and citric acid 
(The exact recipe for this placebo can be found in Appendix Q).  The placebo has 
a red color in appearance due to the Crystal Light flavoring.  Thus both of the 
RockStar  drinks will be given a teaspoon of Crystal Light flavoring to make 
them red and to further aid in making the flavors similar.  All treatments will be 
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kept in a refrigerator in the laboratory preparation room on the ASU Polytechnic 
campus.   
 Once a subject was assigned his treatment, he was given ten minutes to 
consume this beverage and then given 15 more minutes to complete the POMS. 
The muscular testing was begun within 30 minutes of finishing drinking the 
treatment.  Previous studies have seen significant ergogenic effects over a range 
of 10 minutes to 60 minutes post-treatment (Alford et al., 2001), (Duchan et al., 
2010), (Forbes et al., 2007), (Hoffman et al., 2009), (Horne & Reyner, 2001),  
(Ivy et al., 2009), (Lockwood et al., 2010), (Mets et al., 2011), (Smit et al., 2004).  
Additionally, most of these studies saw benefits as early as 30 minutes post-
treatment and even earlier such as 10-15 minutes post-treatment (Alford et al., 
2001), (Duchan et al., 2010), (Hoffman et al., 2009), (Horne & Reyner, 2001), 
(Lockwood et al., 2010), (Mets et al., 2011), (Smit et al., 2004).  This smaller wait 
time before commencement of exercise more closely resembles the authentic way 
young adults use these energy drinks as supplements for physical activity; energy 
drinks are usually consumed rapidly with exercise beginning just minutes after 
consumption.   
Body Composition 
 Each subject had their body fat percentage measured by Bod Pod.  The 
Bod Pod uses air displacement plethysmography to measure an individual’s 
whole-body density (Powers & Howley, 2010).  Air displacement 
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plethysmography acquires a body volume measurement by detecting small 
changes in pressure caused by the individual sitting inside the chamber.   This 
pressure difference conveys that the volume of air has changed compared to an 
empty chamber, giving an air volume value that can then be used to calculate the 
volume of the individual sitting inside the Bod Pod (Powers & Howley, 2010).   
From this measurement of body volume, a calculation is done by the Bod Pod to 
obtain the whole-body density of the individual (Powers & Howley, 2010).  The 
whole-body density is then used in the Siri equation to calculate the percentage of 
body fat (Powers & Howley, 2010).  Constant values of human fat tissue (0.900 
g/ml) and fat free tissue (1.100 g/ml) are the basic assumptions when using the 
Siri equation to calculate the body fat percentage using a person’s whole-body 
density (Powers & Howley, 2010).  The Siri equation is a population specific 
equation for Caucasian males, therefore this will be a source of error when 
measuring body composition for other ethnicities and races in the BodPod.   
 Siri Equation:   % Body Fat = (495/Density) - 450 (Powers & Howley, 2010) 
  In order to attain the most accurate measurement of body fat percent, 
individuals were required to wear a cap on the head to condense the hair and 
minimal, form-fitting clothing to prevent any additional air displacement caused 
by loose hair and clothing (Bod Pod: COSMED Pulmonary Function Equipment, 
1850 Bates Avenue, Concord, CA 94520).   
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POMS Questionnaire 
 The Profile of Mood States questionnaire was administered to each subject 
prior to muscle testing to determine his current feelings of vigor and fatigue.  It is 
a self-report assessment that provides subjective scores for the following six 
scales: Tension-Anxiety, Anger-Hostility, Fatigue-Inertia, Depression-Dejection, 
Vigor-Activity, and Confusion-Bewilderment (POMS: San Diego Educational 
and Industrial Testing Service, 1971).  The POMS Standard is appropriate for 
subjects 18 years and older and will be the version used for this study.   
According to McNair et al, the POMS can be administered with a frequency of 
once per week due to an acceptable proven level of test-retest reliability, in 
addition to a well demonstrated satisfactory level of internal consistency (McNair, 
Lorr, & Droppelman, 1971).  The POMS consists of 65 questions spanning the six 
scales, will take about 10-15 minutes to complete, and is hand scored (McNair, 
Lorr, & Droppelman, 1971).  The complete questionnaire can be found in 
Appendix J.          
Isokinetic Assessment 
 The HUMAC NORM machine is a testing and rehabilitation system 
widely used in varying environments such as physical therapy clinics, personal 
training programs, and research laboratories, offering four resistance modes 
(isokinetic, isotonic, isometric, and passive) and 22 isolated-joint movement 
patterns (Hillery, 2010: HUMAC NORM: CSMi Medical Solutions,  101 Tosca 
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Drive, Stoughton, MA 02071).  A comparison of upper body and lower body 
extremities were measured on an isokinetic dynamometer as a valid measure of 
muscle strength (Charteris, 1999).  More than 1000 studies have used this 
machine in various ways, including utilizing it as a tool to measure isokinetic 
muscle strength and fatigue (Hillery, 2010).   
 In this study, three different tests were conducted to measure peak 
hamstring and quadriceps strength using the isokinetic mode for the knee 
extension.  Three different frequencies or speeds (240, 180, and 60 degrees/sec) 
were used for extension and flexion of each knee.  At each frequency a “practice” 
set was given followed by the “real” test of peak torque.  Muscle fatigue was 
assessed by a test consisting of 50 repetitions of flexion and extension at a high 
frequency of 240 degrees per second. This test results in a fatigue index curve that 
shows the decline in strength and power over time.  The leg to be tested first will 
be randomly selected by the paper method described in the randomization section.   
 Each subject was asked to sit on the bench/seat of the isokinetic machine 
while harnessed into three straps to stabilize his upper body during testing.  The 
straps were tightened to keep the subject firmly pressed against the back of the 
chair.  Another strap was placed across the thigh and a strap with a cushion was 
secured around the leg just above the ankle to isolate the leg being tested.  The 
seat and knee angle of extension was adjusted identically prior to the start of each 
testing session.  Each subject was given the same level of encouragement for each 
trial.  The detailed procedure for this test can be found in Appendix K.            
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Procedures 
Week 1 
 The subject arrived at the laboratory, a quiet and activity-free room, in the 
morning in a normally hydrated state at a scheduled time.  He was greeted and 
directed to sit at a table to read and sign the consent form.  Once the consent form 
was signed, he was asked to complete a Physical Activity Readiness 
Questionnaire (Par-Q), a medical history questionnaire, a survey of daily beverage 
consumption, and to record what he ate for dinner the night before.  He was also 
given 15 minutes to complete the POMS questionnaire prior to the 
commencement of measurements.  He was asked to remove his shoes and socks to 
have his height measured by a wall-mounted stadiometer to the nearest 0.5 cm.  A 
second measurement was taken using the Bod Pod to obtain a percent body fat 
value.  The investigator directed the subject to the room where the Bod Pod was 
located and asked the subject to remove all excess clothing, so he was only 
wearing form-fitting shorts, briefs, or other type of form-fitting clothing chosen, 
and to put on a cap if he had hair that was not close-cropped to his head.  While 
the subject readied himself for Bod Pod measurement, the investigator calibrated 
the machine.  The investigator then input the subject’s information such as date of 
birth, height, and weight into the computer attached to the Bod Pod.  The subject 
was directed to sit in the Bod Pod chamber, making sure to remain still during the 
measurement process (approximately 2 minutes).  The investigator opened the 
chamber door so the subject could step out of the Bod Pod.  While the investigator 
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printed the measurement results, the subject re-dressed and they both went back to 
the laboratory to proceed with a familiarization trial on the isokinetic 
dynamometer.  The investigator asked the subject to put on a heart rate monitor 
while she input his information into the computer and randomly selected one of 
two pieces of paper to determine which leg was to be tested first.   The 
investigator set up the machine appropriately for the leg that was chosen to be 
tested first and asked the subject to sit in the seat.  His thigh and calve were both 
firmly strapped down to isolate the testing leg and his upper body was firmly 
strapped to the back of the chair by a harness with two straps from shoulder to 
waist and a strap across the abdomen.  Testing then took place and once all three 
frequencies (240, 180, 60 degrees/second) were tested, the subject underwent a 
test to fatigue on the same leg using a frequency of 240 degrees/second.  The 
same procedure was followed for the other leg and encouragement was given to 
motivate the subject to do well throughout testing.  Once all initial measures were 
obtained and the familiarization trial completed, the investigator and the subject 
planned the next three visits to take place at a similar time on the same day of the 
week when possible.  Each testing session was separated by a minimum of seven 
days to allow for complete washout of treatments and to account for any muscle 
soreness due to isokinetic testing.  The subject was given a brief description of the 
next three visits, advised to eat the same reported dinner the night before his next 
testing session, fast for 8 hours, and abstain from alcohol and caffeine ingestion 
for 24 hours prior to his next visit, and contacted by email and/or phone call four 
days later and one day before his next visit as additional reminders.  Total time for 
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the week 1 familiarization trial session was approximately one hour twenty 
minutes.   
Weeks 2, 3, and 4 
 Weeks 2, 3, and 4 were the experimental weeks of this study when each 
subject received a randomly selected treatment.  The subject arrived at the 
laboratory in a normally hydrated, fasted state at his scheduled time.  While the 
subject was directed to sit at a table, a person other than the investigator prepared 
the treatment in a different room.  The subject was given ten minutes to consume 
this beverage and was asked to record his previous night’s dinner.  Once the 
subject finished consuming his beverage, he was given 10-15 minutes to complete 
the POMS after which he was asked to strap on a heart rate monitor around his 
chest.  Isokinetic testing on the HUMAC NORM commenced 15 minutes post-
treatment.  After completing muscle strength testing, the investigator confirmed 
the time and date of the next session with the subject and he was then free to 
leave.  The investigator contacted the subject one week later and one day before 
to remind him of his next scheduled time and date in addition to consuming his 
reported dinner, abstaining from caffeine and alcohol ingestion for 24 hours prior 
to the next session and arriving in a fasted state.  Each session thereafter followed 
the same protocol with randomization and blinding procedures continuing with 
each treatment until all treatments were assigned to each subject.  The last 
session, week 4, included an additional measurement in the Bod Pod.  The 
treatment sessions lasted a total of approximately one hour and the final treatment 
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session lasted approximately one hour and ten minutes.  Subject information 
sheets for Visits 1 and 2, 3, and 4 are included in Appendices O, P, Q, 
respectively.       
Subject Sample Size 
 A minimum of 10 subjects were needed for participation in this study to 
have an 84% probability that all data collected and significance levels (.05) were 
true and not due to chance with a minimal mean difference of 1.5 and 80% power  
(Schoenfeld, D.A., 2010).  Therefore, 20 subjects were recruited to account for 
attrition over the 8-9 week period.    
Statistical Analysis 
 Data were assessed for normality using the Shapiro-Wilk Test for 
normality (n≤50).  Descriptive data were analyzed and reported as mean ± SD.  
Any variables that were deemed abnormal were transformed into normal variables 
when possible; non-parametric tests were used when this was not possible.  For 
normal variables, Pearson’s correlations were used to assess any associations 
between anthropometric measures and Profile of Mood States (POMS) Vigor and 
Fatigue subscores, peak torque, total work, and fatigue index values.   For non-
normal variables, Spearman’s Rho was utilized to determine if there were any 
correlations between anthropometric measures and POMS Vigor and Fatigue 
subscores, peak torque, total work, and fatigue index values.  A Paired Samples 
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T-Test was used to analyze differences between weight, body fat percent, and lean 
mass from visits 1 and 4. 
  A Mixed Models analysis was used to assess differences in knee extensor 
and flexor peak torque, total work, and fatigue index values between treatments.  
Mixed Models analysis was also used to assess group differences in POMS 
subscores for Vigor and Fatigue at each time period by treatment.  Furthermore, 
this Mixed Models analysis was also used to determine interactions by time to 
account for a learning effect.  Additionally, all isokinetic values and POMS 
subscores values were covaried by habitual caffeine intake and anthropometric 
measures in the Mixed Models analysis.  Caffeine intake, weight, body fat 
percent, and lean mass were used as covariates in the Mixed Models analysis to 
account for confounding variables.  The statistics program SPSS 19 was used to 
complete all statistical assessments.  
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Chapter 4 
RESULTS 
Normality  
 All statistical analysis was completed using the SPSS 19.0 program.  
Normality tests were completed using the Shapiro-Wilk test for normality (n<50).  
Subject 2 was removed from all data because his measures were outliers for a 
majority of the variables.  All anthropometric measures were normal except for 
body fat percent 2 (p=0.009).  All POMS Vigor subscores were normal, however, 
only the ORS condition for POMS Fatigue subscores was normal.  Table 7 
contains all of the Fatigue and Vigor subscores collected from the POMS 
questionnaire over the 3 experimental visits.  All peak torque and total work 
measures were normal.  All fatigue index measures were normal except the Right 
Extensors under the SFRS condition (p=0.019).  This fatigue index measure did 
not normalize when transformed using log or square root functions, so non-
parametric tests (Spearman’s Rho) were used to investigate this variable while 
Pearson’s correlations were used for the normal variables.     
Anthropometric Variables 
 Table 4 contains the anthropometric measures obtained during the study.  
There were a total of 9 males that completed the study, however, due to an 
abundance of outlier variables for 1 subject, his data was omitted from the 
statistical analysis.  Therefore, the following data represent a total of 8 males.  
Males with a mean age of 23.3 years and mean height of about 181 centimeters 
had an average weight of 85.3 kilograms at the first visit (Wt 1) and 84.2 
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kilograms at the last visit (Wt 2).  Body fat percentages at the first visit (BF% 1) 
averaged 17.8% and at the last visit (BF% 2) averaged 17.3%.  So, according to 
these data there was an average weight loss of 1.1 kilograms.  This weight loss 
can be contributed mainly to one subject who lost 10.4 kilograms during the study 
with instructions to maintain the same weight throughout the study.  This same 
subject also had a loss of 4.4% body fat by the end of the study, contributing to 
the difference in the two measures of body fat percentage in Table 1.  The 8 males 
had a mean BF% 1of 17.8% and BF% 2 of 17.3%.  A net mean loss of 0.5% body 
fat occurred.  When analyzing differences between Wt 1 and Wt 2, BF% 1 and 
BF% 2, and Lean Mass 1 (LM 1) and Lean Mass 2 (LM 2) using a Paired 
Samples T-Test, there were no significant differences (p=0.455, p=0.516, and 
p=0.467, respectively).  The final variables that were calculated from measures 
obtained during the study were change in weight (ChangeWt) and change in body 
fat percent (ChangeBF).  ChangeWt was calculated by subtracting Wt 1 from Wt 
2, so a positive number was equivalent to weight gain whereas a negative number 
is equivalent to weight loss.  The mean ChangeWt for these 8 subjects was -1.1 
kg, which indicates a net weight loss.  ChangeBF was calculated by subtracting 
BF%1 from BF%2, so a positive number shows a gain in body fat percent and a 
negative number shows a loss in body fat percent.  The mean ChangeBF in these 
8 subjects was -0.54% which indicates an overall loss in body fat percent.      
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Table 4: Anthropometric Variables 
   
 
  
Mean Standard 
Deviation P (n=8) 
Age (years) 23.3 4.3   
Height (cm) 181.0 5.3   
Wt 1 (kg) 85.3 12.6   
Wt 2 (kg) 84.2 14.3 0.455 
Mean Wt (kg)* 84.8 14.1   
BF% 1 17.8 5.2   
BF% 2  17.3 6.1 0.516 
Mean BF%** 17.6 5.5 
 LM 1 (kg) 70.0  8.3   
LM 2 (kg) 69.0  8.6 0.467  
Mean LM (kg)*** 69.3  8.3   
CI**** 1.6 0.7   
*Mean Wt (kg) = Weight 1 + Weight 2 
**Mean BF% = BodPod%Fat1 + BodPod%Fat2 
***Mean LM (kg) = Lean Mass 1 + Lean Mass 2 
****(CI) Caffeine intake is equivalent to the amount of 8 fluid ounce drinks 
consumed per week (#/7), calculated using answers from the beverage survey.  
The calculations yielded numbers ranging from very low (0.5) to very high (24).  
The numbers were grouped as follows: 0=none to very little (0-3), 1=average (4-
7), 2=high (8-14), and 3=very high (15-24).  
 
Isokinetic Variables 
 In regard to the question of whether there would be any differences 
between treatments (ORS, SFRS, and PL) on Peak Torque (PT) at 60°/sec, 
180°/sec, and 240°/sec, Mixed Models analysis demonstrated no significant 
differences (p≥0.05).  Table 5 contains all of the PT measures that were obtained 
throughout the study on 8 subjects.   
 Pearson’s correlations were conducted on PT60 values for all treatments 
and all variables.  Several PT60 relationships were demonstrated with age, such as 
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ORS right and left flexors (r=.776, p=0.024 and r=.769, p=0.026 respectively), Pl 
right and left flexors (r=.764, p=0.027 and r=.771, p=0.025 respectively), and 
SFRS left flexors (r=.735, p=0.038).  Significant positive relationships were 
demonstrated between Wt 1 and PT60 ORS right and left extensors (r=.744, 
p=0.034 and r=.869, p=0.005 respectively), PT60 Pl right and left extensors 
(r=.788, p=0.023 and r=.728, p=0.041, respectively), and PT60 SFRS left 
extensors (r=.728, p=0.036).  Next, PT60 ORS right and left extensors were 
strongly correlated with Wt 2 (r=.747, p=0.033 and r=.851, p=0.007 respectively) 
as well as PT60 Pl right and left extensors (r=.769, p=0.026 and r=.749, p=0.032 
respectively).  Furthermore, there was a positive correlation between PT60 and 
Wt 2 was the Pl left flexors with a strong correlation of r=.729 with significance 
p=0.040.  Additionally, ChangeBF was positively correlated to PT60 ORS, Pl, 
and SFRS left flexors (r=.769, p=0.026 and .863, p=0.006 and r=.765, p=0.027 
respectively), PT60 Pl left extensors (r=.732, p=0.039), and PT60 SFRS right 
extensors and flexors (r=.735, p=0.038 and r=.821, p=0.012 respectively).  
Finally, BF%2 had a strong positive correlation with PT60 ORS left extensors 
(r=.796, p=0.018).  
 Next, Pearson’s correlations were completed for PT180 under all 
treatments with all variables.  First, PT180 ORS and Pl left extensors had 
significant positive correlations with Wt 1 (r=.716, p=.046 and r=.727, p=0.041 
respectively).  The second variable, Wt 2, was positively correlated to PT180 
ORS and Pl left extensors (r=.784, p=0.021 and r=.759, p=0.029 respectively).  
Also, PT180 measures of ORS right and left flexors (r=.847, p=0.008 and r=.866, 
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p=0.005) and Pl right extensors and right flexors (r=.816, p=0.013 and r=.860, 
p=0.006 respectively) demonstrated strong correlations with age.  BF%2 had a 
positive relationship with PT180 ORS left extensors (r=.744, p=0.034).  Finally, 
PT180 Pl left flexors had a positive relationship with ChangeWt (r=.771, 
p=0.025) and PT180 SFRS left extensors had a positive relationship with 
ChangeBF (r=.740, p=0.036).  
 The PT240 ORS left flexors and Pl left extensors had strong correlations 
with Wt 1 (r=.787, p=0.020, and r=.771, p=0.025 respectively) according to a 
Pearson’s correlation.  Furthermore, PT240 ORS left flexors and Pl left extensors 
were strongly correlated to Wt 2 (r=.835, p=0.010 and r=.740, p=0.036 
respectively).  The only PT240 measure to strongly correlate with age was ORS 
right flexors (r=.928, p=0.001).  Also, PT240 Pl left extensors were positively 
correlated with BF%1 (r=.782, p=0.022).  PT240 ORS left flexors (r=.725, 
p=0.042), and PT240 Pl left extensors (r=.887, p=0.003) were also positively 
correlated with BF%2.  ChangeWt was strongly associated with PT240 Pl left 
flexors and (r=.752, p=0.031) and with PT240 SFRS left extensors (r=.772, 
p=0.025).  Lastly, PT240 Pl right and left flexors (r=.723, p=0.043 and r=.731, 
p=0.039 respectively) were positively associated with ChangeBF.               
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Table 5: Peak Torque Measures in Newton-meters 
(mean ± standard deviation) 
 
  
Original 
RockStar 
Sugar-free 
RockStar Placebo 
P 
60 °/second 
 
   
R Flex 106.4 ± 28.8 109.9 ± 22.2 107.8 ± 27.5 
0.965 
L Flex 95.4 ± 24.9 102.6 ± 24.1 98.4 ± 28.0 
0.853 
Mean 
Flexors 100.9 ± 26.1 106.3 ± 22.3 103.1 ± 27.2 
 
R Ext 186.6 ± 66.4 184.4  ± 49.3 169.4  ± 56.0 
0.811 
L Ext 187.3 ± 63.5 179.3 ± 48.4 169.5 ± 49.7 
0.809 
Mean 
Extensors 186.9 ± 63.7 181.8 ± 47.8 169.4 ± 52.5 
 
180 °/second 
  
 
R Flex 75.12 ± 14.9 84.1 ± 14.9 81.4 ± 14.9 
0.478 
L Flex 71.5 ± 17.3  79.0 ± 15.2  74.5 ± 15.6 
0.648 
Mean 
Flexors 73.3 ± 14.8 81.6 ± 14.3 77.9 ± 27.2 
 
R Ext 103.9 ± 25.7 118.4 ± 31.4 103.9 ± 25.6 
0.493 
L Ext 125.1 ± 37.4 117.1 ± 21.7 115.9 ± 33.3 
0.818 
Mean 
Extensors 114.5 ± 26.9 117.8 ± 25.9 109.9 ± 27.7 
 
240 °/second 
 
  
 
R Flex 71.3 ± 10.2 74.5 ± 14.8 70.3 ± 10.6 
0.764 
L Flex 69.0 ± 11.1 75.1 ± 16.2 65.6 ± 12.8 
0.380 
Mean 
Flexors 70.1 ± 9.8 74.8 ± 14.1 67.9 ± 10.9 
 
R Ext 99.3 ± 24.0 92.9 ± 22.6 91.1 ± 22.1 
0.760 
L Ext 107.3 ± 28.8 104.0 ± 23.7 98.1 ± 21.8 
0.762 
Mean 
Extensors 103.3 ± 24.8 98.4 ± 21.1 94.6 ± 15.5 
 
Mean Flexors= R & L Flexors values by treatment 
Mean Extensors= R & L Extensors values by treatment 
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 A Mixed Models analysis of FI measures revealed no significant 
differences between treatments (p≥0.05).  Table 6 displays all of the FI values of 
8 subjects under all three treatment conditions.  Pearson’s and Spearman’s Rho 
(SFRS right extensors) correlations conducted on FI measures under all 
treatments and all variables illustrated numerous significant relationships.  For 
example, FI ORS right flexors showed a very strong and significant correlation 
with Wt 1 (r=.924, p=0.001).  Correlations with Wt 2 demonstrated a relationship 
with the FI ORS right flexors (r=.835, p=0.010).  Furthermore, Spearman’s Rho 
demonstrated a strong and significant correlation between caffeine intake and FI 
SFRS right extensors (r=.818, p=0.013).  In addition, BF% 1 was correlated to FI 
ORS left flexors (r=.749, p=0.033) using Pearson’s correlation which showed a 
significant relationship.  Next, Spearman’s Rho showed a significant negative 
correlation between BF%1 and FI SFRS right extensors (r=-.755, p=0.031).  
Lastly, FI ORS right flexors had a strong association to BF%2 (r=.760, p=0.028).    
 There were no significant differences in TW measures between treatments 
according to a Mixed Models analysis (p≥0.05).  All TW values can be seen in 
Table 6 for the three different treatments.  Subsequently, Pearson’s correlations 
exhibited relationships between Wt 1 and TW values from ORS and Pl right 
extensors (r=.720, p=0.044 and r=.819, p=0.013 respectively) and in TW values 
from ORS and Pl left extensors (r=.794, p=0.019 and r=.768, p=0.026 
respectively).  The TW measures that had strong correlations with Wt 2 were 
ORS left extensors (r=.813, p=0.014) and Pl right and left extensors (r=.755, 
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p=0.030 and r=.741, p=0.036 respectively).  Additionally, TW measures that 
strongly correlated with BF%2 were ORS left extensors (r=.728, p=0.041) and Pl 
left extensors (r=.722, p=0.043).      
 Mixed Models analyses were also completed on all individual isokinetic 
variables with treatment as the factor and caffeine intake and anthropometric 
variables as covariates to account for possible confounders in the data.  
Specifically, Age, Mean Wt, Mean LM, Mean BF%, and CI were used as 
covariates in these analyses.  Out of all twenty isokinetic variables (PT at three 
different speeds, TW at one speed, and FI at one speed) there was only one that 
showed significance by treatment with the above mentioned variables used as 
covariates.  The right extensors during PT60 showed significant differences 
(p=0.002) between treatments when accounting for Mean Wt (kg).  Lastly, a 
learning effect was accounted for by covarying by time which showed no 
significant differences in any of the isokinetic variables by treatment (p≥0.05).        
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 Table 6: Fatigue Index and Total Work Measures at 240 °/second 
(mean±standard deviation) 
      
  
Original               
RockStar 
Sugar-free 
RockStar Placebo P 
Fatigue 
Index 
(%) 
 
 
  
 
R Flex 53.9 ± 7.3 49.0 ± 8.8 43.8 ± 10.4 1.00  
L Flex 51.8 ± 9.8 48.8 ± 12.6 50.4 ± 10.7 0.864  
Mean 
Flexors 52.8 ± 7.3 48.9 ± 9.6 47.1 ± 9.2 
 
R Ext 43.3 ± 14.6 48.3 ± 11.0 43.6 ± 17.5 0.751  
L Ext 44.3 ± 15.0 41.0 ± 12.3 45.9 ± 16.3 0.796  
Mean 
Extensors 43.8 ± 14.2 44.6 ± 10.5 44.8 ± 16.6 
 Total Work  
(N-m) 
 
 
    
R Flex 2463.8 ± 548.5 2294.5 ± 524.0 2450.1 ± 486.9 0.773 
L Flex 2108.6 ± 489.8 2214.3 ± 505.2 2174.3 ± 372.4 0.868  
Mean 
Flexors 2286.2 ± 498.6 2254.4 ± 489.9 2312.2 ± 403.4 
 
R Ext 3540.9 ± 730.9 3389.8 ± 472.5 3519.1 ± 608.5 0.868  
L Ext 3562.6 ± 505.6 3605.0 ± 436.6 3662.8 ± 561.4 0.90  
Mean 
Extensors 3551.8 ± 606.0 3497.4 ± 329.6 3590.9 ± 558.6 
 Mean Flexors = R & L Flexors values by treatment 
Mean Extensors = R & L Extensors values by treatment 
 
 
 
Profile of Mood States Subscores 
 A Mixed Models analysis comparing the effects of the three treatments 
(ORS, SFRS, and Pl) on POMS Vigor and Fatigue subscores showed no 
significant differences (p≥0.05).  Table 7 displays all of the measures obtained 
throughout the study on feelings of POMS Fatigue and Vigor.  Pearson’s 
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correlations were then performed on all POMS subscores with all other variables.  
A strong correlation was seen with Age and Pl POMS Vigor subscores (r=.719, 
p=0.045).  BF%1 was negatively correlated to baseline POMS Fatigue subscores 
(r=-.763, p=0.028).  Finally, ChangeBF had strong correlations with Pl and SFRS 
POMS Vigor subscores (r=.781, p=0.022 and r=.943, p=0.00 respectively). 
 
Table 7: Profile of Mood States SubScores 
 
  
 
Original 
Rockstar 
Sugar-free 
RockStar 
Placebo 
 P 
POMS 
Fatigue  2.5 ± 2.5 2.9 ± 5.2 1.3 ± 2.2 0.730 
Mean 
Fatigue* 2.2 ±2.8  
POMS Vigor 17.1 ± 7.0 18.1 ± 5.1 18.0 ± 6.7 0.966 
Means 
Vigor** 17.8 ± 5.7  
 *Mean Fatigue (POMS F) = mean of all POMS Fatigue subscores under all three 
treatments 
**Mean Vigor (POMS V) = mean of all POMS Vigor subscores under all three 
treatments  
   
 In addition, all POMS Fatigue and Vigor subscores were also analyzed by 
a Mixed Models test with treatment as the factor and caffeine intake and 
anthropometric variables as covariates.  The same covariates were used as the 
analyses completed in the isokinetic variables: Age, Mean Wt, Mean LM, Mean 
BF%, and CI.  When covarying for each of these variables, there still were no 
significant differences in POMS subscores between treatments (p≥0.05).  Also, 
using time as a covariate showed no significant differences in POMS subscores of 
Fatigue and Vigor by treatment (p≥0.05).       
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Pearson’s Correlations for Overall Data  
 Since there were no significant differences between treatments on 
measures of muscular endurance and fatigue or on POMS subscores (p≥0.05), all 
of the data points for each variable were combined to create one singular variable 
for each subject.  For example, all PT60 data points under the different treatments 
for right flexors and extensors and left flexors and extensors were combined into 
one variable (Mean PT60).  PT60 was the only PT measure to be meaned in this 
manner because it was the most important PT measure taken during the study, 
requiring the most effort of all the PT measures.  Other data points that were 
combined into one variable include Mean Wt (kg) (Wt 1 and Wt 2), Mean BF% 
(BF% 1 and BF% 2), Mean LM (kg) (LM 1 and LM 2), Mean TW, Mean FI, 
POMS F (all POMS Fatigue subscores for the three treatments), and POMS V (all 
POMS Vigor subscores for the three treatments).   
 Pearson’s correlations completed to investigate relationships between 
Mean PT60 and the other meaned variables demonstrated significant correlations 
with Mean Wt (r=0.780, p=0.022), Mean LM (r=0.728, p=0.041) and Mean TW 
(r=0.793, p=0.019).  Additionally, positive relationships were demonstrated 
between Mean PT60 and Age (r=0.671, p=0.069) as well as Mean PT60 and 
POMS V (r=0.687, p=0.060) that were not significant but trended towards being 
significant.  Next, Pearson’s correlations demonstrated no significant relationships 
between Mean FI and any of the aforementioned variables.  A positive 
relationship was shown between Mean TW and Age (r=0.686) but this was not a 
significant relationship (p=0.060).  Additionally, Pearson’s correlations 
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demonstrated a significant positive relationship between POMS V and Mean LM 
(r=0.748, p=0.033) as well as a positive relationship between POMS V and Age 
(r=0.653) which was not significant (p=0.079).  Lastly, significant positive 
correlations between Mean LM and Mean Wt (r=0.903, p=0.002) and Mean BF% 
and Mean Wt (r=0.773, p=0.025) were made obvious.  These correlations can be 
seen in Table 8 with each variable abbreviated as follows: Age, Wt, BF%, LM, 
PT60, TW, FI, POM F (POMS F), and POM V (POMS V).         
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Table 8: Correlations Table for Overall Data 
 
Age 
Wt 
(kg) BF% 
LM 
(kg)  PT60 TW FI 
POM 
F 
POM 
V 
Age 1 
        
Wt 
(kg) 0.15 1 
       
BF% -0.16 0.77* 1 
      
 LM 
(kg) 0.29 0.90* 0.43 1 
     
PT60 0.67♦ 0.78* 0.55 0.73* 1 
    
TW 0.69♦ 0.40 0.25 0.39 0.79* 1 
   
FI -0.49 0.03 0.49 -0.29 -0.19 -0.53 1 
  
POM 
F 0.33 0.01 0.02 0 0.27 0.12 0.12 1 
 
POM 
V 0.65♦ 0.54 0.00 0.75* 0.69♦ 0.61 -0.61 0.26 1 
 *Significant correlations (p<0.05)   ♦Trend towards significance (p≥0.05)  
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Chapter 5 
DISCUSSION 
Rationale  
 The 1997 introduction of Red Bull energy drink to the beverage market 
was followed by a barrage of several other energy drink brands, all with a main 
target audience consisting of adolescents and young adults (Reissig, Strain, & 
Griffiths, 2009).  Although these high caffeine and herbal infusions claim to 
provide ergogenic and cognitive enhancements, research has not conclusively 
confirmed or denied these assertions.  Utilization of these types of beverages has 
seen predominant increases among the physically active young adult population, 
especially in males (Froiland et al., 2004; Walsh et al., 2010).  Therefore, this 
study investigated the possible ergogenic effects of energy drinks in acute muscle 
strength and endurance and POMS subscores for Fatigue and Vigor.  Eleven men 
who fit the prerequisites for participation in this study were recruited while only 
nine subjects completed all four visits.  The last two subjects (10 and 11) recruited 
only completed the first visit due to scheduling conflicts which led to time 
constraints for finishing the last three visits.  One of the nine subjects who 
completed all four visits had numerous outlier values (values more than two 
standard deviations below values for the other eight subjects) so his data were 
excluded from the study; after removing his data, several of the non-normal 
variables became normal with the exception of the Fatigue Index SFRS right 
extensors values.  There were no drop-outs in this study, however, the subject 
sample size was very small (n=8) and did not meet minimum requirements for 
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power of the study (n=10).  Therefore, this sample was too small to strongly 
represent the active but non-athlete 18-30 year old males in the United States.  For 
example, the anthropometric measures of the subjects were slightly higher than 
the 18-30 year old males recruited to participate in a study comparing athletic 
status differences in peak torque, total work, and average power during isokinetic 
contractions of the knee flexors and extensors (Siqueira, Pelegrini, Fontana, & 
Greve, 2002).  Moreover, a mean weight of 85.3 kg, height of 181 cm, and age of 
23.3 years are higher means compared to Siqueira’s control group of males whose 
mean weight was 71.1kg, mean height was 174.6 cm, and mean age was 20.5 
years (Siqueira, Pelegrini, Fontana, & Greve, 2002).  When comparing the 8 
subjects’ anthropometric measures to the 9 collegiate athletes from Wyse’ study 
of time of day effects on isokinetic leg strength, his athletes had a lower mean age 
(19.6 years), lower mean weight (76.5 kg), but the same mean height (181 cm) 
(Wyse, Mercer, & Gleeson, 1994).  According to ACSM’s 8th Edition of 
Guidelines for Exercise Testing and Prescription, the subjects in this study 
(BF%1= 17.8%, 5.21 and BF%2= 17.3%, 6.05) (mean, std dev) were categorized 
into the “fair” category for the 20-29 years age group (BF%= 17.4-18.6%) 
(ACSM, 2010).  The males in this study also had what was considered an “above 
average” caffeine intake (1.63, 0.71) (mean, std dev) which can be interpreted as 
having at least 1 caffeinated beverage each day of the week. 
Isokinetic Variables 
 According to a Mixed Models analysis, there were no differences in PT 
measures at any of the three speeds (60°/sec, 180°/sec, and 240°/sec) between 
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treatments (p≥0.05).  PT values in this study were measured acutely and were 
isolated to extension and flexion at the knee joint.  This type of measure did not 
require any muscle endurance and was therefore mainly gauging each subject’s 
strength and power in the quadriceps and hamstrings muscles within a matter of 
seconds.  The best test of isokinetic strength is the PT test at 60°/sec (Flansbjer & 
Lexell, 2010; Kannus, 1994; Scudder, 1980; Siqueira et al., 2002).  Subsequently, 
after completing the Mixed Models analysis, only the PT60 measures were used 
to investigate correlations to determine if there were any general patterns in the 
data.  Since there were no significant differences between treatments for any 
PT60 values or between the right and left flexors and extensors, all of these 
individual measures were combined into one variable, Mean PT60 (this value is 
displayed in Table 5).  As displayed in Table 8, Mean PT60 was significantly 
positively related to Mean Wt and Mean LM, exhibiting a relationship between 
the amount of lean mass one has with performance in PT60 measures.  This 
correlation agrees with Lue et al’s finding that anthropometric variables such as 
weight and percent body fat “influence strength performance” with the greatest 
muscle strength demonstrated in subjects with lower percent body fat and higher 
percent of fat free mass (Lue, Chang, Chen, Lin, & Chen, 2000).  Furthermore, 
Mean PT60 was significantly related to Mean TW.  This positive association, 
which can be viewed in Table 8, demonstrates a relationship between the strength 
of the quadriceps and hamstrings muscle groups and the amount of work 
accomplished in a period of less than 2 minutes (FI test lasted less than 2 
minutes).  Pearson’s correlations also revealed a trend towards significance 
77 
between Mean PT60 and Age (Table 8).  This relationship can be interpreted as 
the older men eliciting higher PT60 values; but, the oldest male in this study was 
age 29.  This trend disagrees with Borges’ study investigating differences in 
isokinetic knee extension and flexion torque between men and women aged 20-70 
years, which found decreases in peak torque as age increased (Borges, 1989).  
However, according to Borges’ data, between males aged 20 years and males 
aged 30 years, there was only a 1 Nm decrease at 12 °/sec and a 24 Nm drop at 90 
°/sec (Borges, 1989).  Moreover, Candow and Chilibeck’s research comparing 
young ( age 23 ± 0.7 years) to older (age 65.5 ± 0.9 years) males in lower body 
muscle torque and power utilizing an isokinetic dynamometer and the knee 
flexion and extension series found that the older males had lower peak torques 
than the younger males in both the knee flexors (103.1 Nm versus 146 Nm) and 
the knee extensors (162.1 Nm versus 217.1 Nm)  (Candow & Chilibeck, 2005).  
Pearson’s correlations (Table 8) also found a positive relationship between Mean 
PT60 and POMS V values suggesting that PT values at 60 °/sec may be able to 
approximate feeling of vigor and energy.  Perhaps, with more subjects completing 
this study, this correlation may have been significant.  No study has investigated 
this relationship in a non-athlete population, but research has used the POMS to 
determine changes in mood after physical activity (Berger & Motl, 2000) and in 
athletes to predict performance (Filaire, Bernain, Sagnol, & Lac, 2001).          
 FI and TW measures showed no significant differences between 
treatments when analyzed using a Mixed Models statistical test.  Likewise, when 
comparing Mean FI to the other pooled variables, there were no significant 
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relationships according to Pearson’s correlations.  Similarly, no significant 
correlations were uncovered between Mean TW and other variables, however, a 
positive relationship was demonstrated with Age that was close to reaching 
significance (p=0.060).  This result indicates that there may have been a 
significant relationship between being older (in the range of 18-30 years) and 
having higher TW values if there had been more subjects that completed the 
study. 
 Further Mixed Models analyses that were completed on all isokinetic 
variables covarying for Age, Mean Wt, Mean LM, Mean BF%, and CI 
demonstrated that only one variable, PT60 right extensors, had significant 
differences between treatments when covaried by Mean Wt (p=0.002).  This may 
be of importance because it shows the possibility that energy drinks could benefit 
PT in the quadriceps muscle in young males 15-20 minutes post-consumption.                
 There are several possible explanations of why RockStar® energy drinks 
had no effect on muscle strength and endurance compared to a caffeine-free and 
sugar-free placebo.  To start with, the caffeine dose in the RockStar® energy 
drinks used this study may have been too low to elicit any ergogenic effects in 
acute PT, TW, and FI measures of muscle strength and endurance.   Each subject 
received a range of 1.6-2.9 mg/kg of caffeine depending on their weight (220-120 
lbs).  For example, Desbrow et al’s study on 9 male cyclists (mean age 29.4 years) 
examining the effect of a low dose caffeine capsule (1.5mg/kg) and a moderate 
dose caffeine capsule (3 mg/kg) taken 1 hour before a steady state cycling time 
trial at 70% VO2peak lasting 2 hours demonstrated no significant improvement in 
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performance (Desbrow, Barrett, Minahan, Grant, & Leveritt, 2009).  Also, an 
examination of sugar-free Red Bull® (2 mg/kg caffeine content) on a run time-to-
exhaustion test at 80% VO2max in university students demonstrated no 
significant differences compared to a decaffeinated sugar-free placebo (Candow, 
Kleisinger, Grenier, & Dorsch, 2009).  Furthermore, a review of the literature 
examining the ergogenic benefits of caffeine on endurance performance found 
that a dose of approximately 6 mg/kg did not elicit any benefits in high intensity 
types of exercise, but this dose did induce increases in endurance types of 
performance (Tarnopolsky, 1994).  The caffeine dose in this study was half of 
what was shown to have ergogenic benefits in endurance exercise, maybe if the 
subjects were given the equivalent of two energy drinks, there may have been 
significant differences in muscle strength and endurance measures compared to a 
placebo.   
 Secondly, this study allotted a 20 minute time period for caffeine 
absorption before muscle testing began which may not have been enough time for 
caffeine to elicit a beneficial effect.  According to Duchan et al, peak plasma 
concentration of caffeine is reached at one hour post-consumption (Duchan, Patel, 
& Feucht, 2010).  This is confirmed by a study investigating the effects of regular 
calorie Red Bull® and low calorie Red Bull® on cardiovascular and neurologic 
functions in undergraduate and graduate students where peak values of saliva 
caffeine (µg/ml) were observed at 60 minutes post-consumption (Ragsdale et al., 
2010).  Furthermore, Greer et al’s performance and metabolism research 
involving 9 healthy men [age 29.1 years (2.7) and weighing 82.2 kg (3.5)] in 
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which the consumption of 6 mg/kg of caffeine demonstrated peak plasma caffeine 
levels 60 minutes post-consumption (Greer, McLean, & Graham, 1998). 
 Another possible reason RockStar® failed to bring about any benefits 
could be that each subject’s normal caffeine consumption may have attenuated the 
effects of the energy drinks.  It has been shown that caffeine use is high in the 
overall population at an average consumption rate of 87% with people consuming 
about 193 mg/day, however, this is much higher in young adults aged 18 years 
and up who tend to consume a daily range of 166-336 mg/day of caffeine 
(Addicott et al., 2009).  This amount of caffeine intake can be considered as 
“chronic” and may lead to adaptations to the beneficial effects of caffeine 
(Addicott et al., 2009).  To illustrate, a review conducted by Ganio and colleagues 
on endurance athletes and caffeine use revealed that one week of caffeine 
abstinence optimized the ergogenic effects of caffeine administration before and 
during exercise (Ganio, Klau, Casa, Armstrong, & Maresh, 2009).      
Profile of Mood States Subscores          
 The baseline POMS Vigor (mean 18.6, std. dev. 4.63) subscores from the 
8 male subjects in this study were comparable to those of  62 college students 
who had a mean POMS Vigor subscore of 16.50 with a standard deviation of 6.47 
(McGowan, Pierce, & Jordan, 1991).  Whereas the POMS Fatigue subscores from 
males in this study (1.63, 1.99) were much lower than the 62 college students’ 
subscores from McGowan et al’s study (mean 8.65, std. dev. 6.86) (McGowan, 
Pierce, & Jordan, 1991).   
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 POMS subscores of Vigor and Fatigue showed no significant differences 
between treatments according to a Mixed Models analysis.  Pearson’s correlations 
conducted on the pooled Vigor (POMS V) and Fatigue (POMS F) subscores with 
other pooled variables exhibited significant relationships with POMS V but not 
with POMS F.  For instance, POMS V was shown to have a significant positive 
relationship with Mean LM and with Age (r and p values can be seen in Table 8).  
These relationships are interesting in that the subjects with higher lean mass (kg) 
and the older subjects (oldest was age 29) had higher feelings of vigor and energy.  
So, in males between the ages of 18 and 30 years, the lean mass (kg) and age of a 
subject may be able to closely predict subscores of Vigor from a POMS 
questionnaire.   
 As for why RockStar® energy drinks did not have an effect on POMS 
Vigor and Fatigue subscores, this may be explained by the low dose of caffeine 
and by each subject’s individual consumption of caffeine.  The low dose used in 
this study (1.6-2.9 mg/kg of caffeine) may not have been enough to improve 
feelings of vigor and to reduce feelings of fatigue, however, the subjects who 
completed this study had extremely low subscores of fatigue (mean 2.2 ± 2.82) 
compared to McGowan et al’s 62 college students (mean 8.65 ± 6.86) (McGowan 
et al., 1991).  Additionally, the subjects were given 10 minutes to consume the 
assigned treatment and then given 15 minutes to complete the POMS 
questionnaire.  So, depending on how quickly they consumed the treatment and 
completed the POMS questionnaire, this may have only given some subjects a 
matter of minutes for caffeine absorption before filling out the entire 
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questionnaire while other subjects may have had a higher absorption time of about 
5-10 minutes by the time they filled in the last question (the range of time is 
unknown).  A further explanation is the effect of each subject’s habitual caffeine 
consumption.  For example, a study by Sigmon et al on the effects of chronic 
caffeine administration in 16 habitual caffeine users who maintained 400mg of 
caffeine daily for 2 weeks demonstrated no effects of caffeine administration on 
cerebral blood flow, electroencephalogram, or on POMS subscores (Sigmon, 
Herning, Better, Cadet, & Griffiths, 2009).  Thus, high caffeine consumption on a 
regular basis may have confounded results on POMS subscores in this study. 
Limitations 
 There were several limitations of this study.  First of all, there were not 
enough subjects to have power (10 subjects required for 80% power with minimal 
mean difference of 1.5), therefore this was a pilot study.  These 8 subjects may 
have ingested other products containing caffeine, such as chocolate, during this 
study within 12 hours of testing which may have affected results.  Additionally, 
individual caffeine intake may have played a role in the lack of caffeine’s 
ergogenic effects after administration during the experimental visits.  The 
ingestion of food within 12 hours of testing was a possibility as well, buffering 
any possible effects of the energy drinks.  Furthermore, each subject, with the 
exception of 1 male, had consumed RockStar energy drink before this study and 
knew how it tasted and smelled so there was a possibility that the subjects were 
able to guess when they were given the Pl which may have affected the amount of 
effort put forth on that particular visit.   Finally, heart rate information may have 
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been useful in determining the level of effort a subject put forth during each visit 
to account for the chance that the subjects knew which visit they were given the 
Pl.  No heart rate monitors were used in this study because this data might have 
given the PI a clue as to which treatment the subject was given, a Pl or an energy 
drink, diminishing the double-blindedness.   
Future Implications 
 Future studies regarding the effects of energy drinks on exercise should 
incorporate a variety of doses of caffeine ranging from 2mg/kg up to 6mg/kg, 
multiple post-absorption times ranging from 10 minutes to 60 minutes, and 
multiple types of exercise such as high intensity interval training, time to 
exhaustion trials, and muscle strength and endurance tests.  Additionally, potential 
benefits of consumption during exercise should also be examined since this is 
another popular method of use (Froiland, Koszewski, Hingst, & Kopecky, 2004; 
Walsh, Gonzalez, Ratamess, Kang, & Hoffman, 2010).  The utilization of 
multiple combinations in a tightly controlled, double-blinded, cross over research 
study with small confidence intervals would be ideal but very expensive and time 
consuming.  Energy drink effects on different types of exercise need to be further 
investigated to have agreement on this topic.  Moreover, Doherty and Smith point 
out that further research needs to be done on “the most effective mode and pattern 
of caffeine administration and subjects’ caffeine habituation” (Doherty & Smith, 
2005).  Because energy drinks have been demonstrated to have adverse affects 
due to their high caffeine content, consensus in the research examining the effect 
of energy drinks on exercise is important.  The small dose used in this study (1.6-
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2.9 mg/kg of caffeine) was not effective on improving acute performance in an 
isolated muscle or muscle group (quadriceps and hamstrings muscles).  More 
research needs to be conducted on endurance type activities and different muscles 
and muscle groups to assertively confirm these results.   
Conclusion 
 Based on the physiological mechanisms of the main ingredients in 
RockStar®, there should have been no differences between treatments in acute 
muscle strength or short term endurance.  The physiology behind caffeine’s 
mechanisms implies that benefits should only be seen in endurance type activities 
due to its role in increasing lipolysis through phosphodiesterase inhibition 
(Ballard, Wellborn-Kim, & Clauson, 2010; Hoffman et al., 2009; Maughan, 
Depiesse, Geyer, & International Association of Athletics, 2007; Wilborn et al., 
2009).  In fact, because caffeine reaches peak plasma concentration at 60 minutes 
(Duchan et al., 2010; Greer et al., 1998; Ragsdale et al., 2010) improvements in 
shorter term performance was unlikely.  However, the purpose of this study was 
to mimic how these energy drinks are consumed “in real life” by men before a 
workout.   Energy drinks are marketed with slogans claiming to increase 
performance in high intensity, strength, and power workouts (Monster Energy 
Company, 2012; Red Bull Gmbh, 2012; ROCKSTAR, Inc., 2012).  Yet, these 
claims have never been substantiated.  Furthermore, although theoretically 
exercise initiated 60 minutes after ingestion should improve performance (Greer 
et al., 1998; Ragsdale et al., 2010), this is not always the case (Astorino et al., 
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2011; Candow et al., 2009; Goldstein, Jacobs, Whitehurst, Penhollow, & Antonio, 
2010).   
 In summary, this study represented a real life situation in which these 
energy drinks are used as a pre-exercise supplement.  This randomized, double-
blinded cross over research study investigating the effects of RockStar energy 
drinks on muscle performance and POMS subscores in healthy young adult males 
found no significant differences in acute muscular strength or endurance 
compared to a placebo.  It is possible that these types of drinks have no ergogenic 
benefits for short term exercise. 
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Week 1: Baseline and Familiarization Visit #1  
  Time: 1 hour 20 minutes   
Week 2: Treatment Visit #2 
 
  
  Time: 1 hour     
Week 3: Treatment Visit #3 
 
  
  Time: 1 hour     
Week 4: Treatment Visit #4     
  Time: 1 hour 10 minutes   
 
 
Baseline & Familiarization Visit #1:  Consent Form     
     Medical History Questionnaire 
     Record Previous Night’s Dinner 
     Daily Beverage Consumption 
     Height measurement 
     Weight/ Body Fat %- Bod Pod 
     POMS Questionnaire 
     Familiarization on Isokinetic Dynamometer 
     Schedule Next 3 Visits 
 
 
Treatment Visits #2 & #3:  Consume Treatment 
Record Previous Night’s Dinner 
     POMS Questionnaire 
     Testing on Isokinetic Dynamometer 
 
 
Treatment Visit #4:   Weight/ Body Fat %- Bod Pod 
     Consume Treatment 
     Record Previous Night’s Dinner 
     POMS Questionnaire 
     Testing on Isokinetic Dynamometer
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CONSENT FORM 
The Effect of an Energy Drink on Acute Muscle Strength and Fatigue in 
Young Men 
 
 
INTRODUCTION 
The purposes of this form are to provide you (as a prospective research study 
participant) information that may affect your decision as to whether or not to 
participate in this research and to record the consent of those who agree to be 
involved in the study. 
 
RESEARCHERS 
Dr. Pamela Swan (FACSM), Associate Professor, Exercise and Wellness, School 
of Nutrition and Health Promotion; and Michelle Hawley have invited your 
participation in a research study. 
 
STUDY PURPOSE 
Previous research has been done on the effect of energy drinks on physical 
performance. None have explored acute muscle strength and fatigue.  Also, none 
have explored the differences between a full sugar version of an energy drink 
and the sugar-free version on muscle strength and endurance to determine if one 
is more beneficial than the other as a pre- workout supplement. 
 
DESCRIPTION OF RESEARCH STUDY 
If you decide to participate, then as a study participant you will join a study 
involving the research of two energy drinks and a placebo in physical activity 
endurance.  Twenty young adult males aged 18-30 years will be screened for 
eligibility and will be asked to visit the lab on four different occasions.  Week 
one’s visit will be comprised of surveys, questionnaires, initial measurements, 
and a familiarization trial on the muscle testing machine.  The initial 
measurements include height, body weight and percent body fat on an electronic 
scale and in the BodPod.  The Bod Pod is an egg shaped chamber that you sit 
inside of while the air pressure around you is measured. You will be required to 
wear a cap on your head and minimal form-fitting non cotton shorts.  You will be 
asked to remove excessive jewelry.  You will then be given fifteen minutes to 
complete a mood questionnaire and then will undergo a practice session for leg 
strength and endurance.  All remaining test sessions will be scheduled at the first 
visit with one week between each session.  You will be asked to report your 
previous night’s meal and advised to eat the same meal the night before each of 
your visits.  Also you will need to refrain from alcohol, caffeine, and physical 
activity for twelve hours, and to fast for at least eight hours.  
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The next three weeks you will be randomly assigned one of the three treatments. 
After entering the lab you will be given ten minutes to consume one of the 
treatments. The experimental treatments are original RockStar, Sugar-Free 
RockStar, and a sugar-free caffeine-free placebo.  The investigator will NOT 
know which treatment you are getting.  The order in which you are assigned 
treatments will be randomly chosen and identified by a letter.  Next you will be 
asked some questions about your previous meals.  You will then be asked to 
complete a fatigue/mood questionnaire.  You have the option to skip any 
questions that you feel you do not want to answer.  Then you will be directed to 
the room containing a muscle testing machine.  The test consists of sitting in a 
chair while your legs and upper body are secured with straps prior to muscle 
testing.  There are 4 test settings or leg movement speeds from hard to very 
easy. There are 30 seconds of rest between each speed.  Each speed requires 2 
practice and then 1 actual measurement of strength.  The endurance test is last 
and consists of 50 repetitions at this easiest setting. The tests last about 5 
minutes total per leg.  
 
If you say YES, then your participation will require four visits to the testing site 
with each visit lasting 1-1.5 hours.  Each visit will be scheduled one week apart, 
so you will be asked to visit the lab every other week at ASU’s Polytechnic 
Campus.  Approximately twenty subjects will be participating in this study. 
 
RISKS 
As with any study, there are potential risks involved in participating in this 
research project.  Increased heart rate and blood pressure, muscle soreness.  
You may have an adverse reaction to caffeine such as nausea, headache, or 
increased heart rate however this should be known prior to acceptance into the 
study. Only subjects who report no previous adverse reactions to caffeine will be 
allowed in the study.  All exercise testing will be conducted by trained staff 
following current ACSM guidelines.    
 
BENEFITS  
The main benefit of your participation in this research study is a current 
measurement of your percent body fat.  A secondary benefit is that you will also 
be provided with your current muscular leg strength, endurance, and fatigue 
measures to assist in future planning of physical activity programs to increase 
muscular strength and endurance in the lower body and/or to evaluate the 
effectiveness of your current physical activity program. 
 
NEW INFORMATION 
If the researchers find new information during the study that would reasonably 
change your decision about participating, then they will provide this information to 
you. 
 
CONFIDENTIALITY 
All information obtained in this study is strictly confidential unless disclosure is 
required by law. 
The results of this research study may be used in reports, presentations, and 
publications, but 
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the researchers will not identify you.  In order to maintain confidentiality of your 
records, 
Michelle Hawley will assign each participant a number to be used in place of their 
names for the duration of the study.  All names and numbers will be kept in a 
locked file cabinet inside of a locked office.  The only persons with access to this 
information will be the principal investigator and the co-investigators. 
 
WITHDRAWAL PRIVILEGE 
It is ok for you to say no. Even if you say yes now, you are free to say no later, 
and withdraw 
from the study at any time.  For any Arizona State University students, staff, or 
faculty, your 
status as a student, grades, and/or employment status will not be affected.  Your 
participation in this study is entirely voluntary.   
COSTS AND PAYMENTS 
The researchers want your decision about participating in the study to be 
absolutely voluntary. 
Yet they recognize that your participation may pose some costs and 
inconvenience.  In order to 
help offset the costs of transportation to and from campus, parking costs, and the 
time required for participation in this study, you will receive a $16.00 Visa gift 
card to be distributed at the completion of the study.  
 
COMPENSATION FOR ILLNESS AND INJURY 
If you agree to participate in the study, then your consent does not waive any of 
your legal rights. However, no funds have been set aside to compensate you in 
the event of injury. 
 
VOLUNTARY CONSENT 
Any questions you have concerning the research study or your participation in 
the study, before 
or after your consent, will be answered by Dr. Pamela Swan, Exercise and 
Wellness Building, 
ASU Polytechnic campus 480-727-1934 or Michelle Hawley, 480-727-1967. 
 
If you have questions about your rights as a subject/participant in this research, 
or if you feel 
you have been placed at risk; you can contact the Chair of the Human Subjects 
Institutional 
Review Board, through the ASU Office of Research Integrity and Assurance, at 
480-965-6788.   
 
This form explains the nature, demands, benefits and any risk of the project.  By 
signing this 
form you agree knowingly to assume any risks involved.  Remember, your 
participation is 
voluntary.  You may choose not to participate or to withdraw your consent and 
discontinue 
participation at any time without penalty or loss of benefit.  In signing this consent 
form, you are 
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not waiving any legal claims, rights, or remedies.  A copy of this consent form will 
be given 
(offered) to you.   
 
Your signature below indicates that you consent to participate in the above study.   
 
 
 
___________________________ _________________________
 ____________ 
Subject's Signature   Printed Name    Date 
 
 
INVESTIGATOR’S STATEMENT 
"I certify that I have explained to the above individual the nature and purpose, the 
potential 
benefits and possible risks associated with participation in this research study, 
have answered 
any questions that have been raised, and have witnessed the above signature. 
These elements of Informed Consent conform to the Assurance given by Arizona 
State University to the Office for Human Research Protections to protect the 
rights of human subjects. I have provided (offered) the subject/participant a copy 
of this signed consent document." 
 
Signature of Investigator______________________________________     
Date_____________ 
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ROCKSTAR FLYER 
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Research Study for Active Men! 
 
*Men Ages 18-30 Needed for a Study on  
Energy Drinks & Muscular Performance* 
 
Perks:  
 $1 6. 00 for 4 visits (approx.  4- 5 hours total) 
 
 Muscle Strength & Endurance Measurements 
 
 Body Fat Percentage Measurements 
 
 Free RockStar Energy Drink 
 
 
Must not be training for an athletic event or sport 
Must be healthy & able to participate in physical activity 
Must not have any negative reactions to caffeine 
 
 *If you are interested in participating in this study, please fill out the 
following survey: https://www.surveymonkey.com/s/6PQSY7N & please contact: Michelle 
Hawley at mhawley3@asu.edu or at 480-727-1967 
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APPENDIX D  
RECRUITMENT SCRIPT 
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 I am a graduate student under the direction of Dr. Pamela Swan, in 
the School of Nutrition and Health Promotion at Arizona State University.  I 
am conducting a research study to determine the effect of RockStar 
energy drink on muscular performance. 
 I am recruiting twenty healthy males between the ages of 18-30 
years old who participate in high intensity exercise no more than three 
times per week.  Each individual will be free of any medical or 
psychological diseases, any adverse reactions to caffeine, and will be 
non-smokers.  Any individual who drinks alcohol excessively, uses illegal 
substances, and/or is not willing to limit his caffeine intake the 12 hours 
prior to each visit will not be considered eligible for participation.   
Each individual will be asked to visit the lab four different times in a 
fasted state.  The first visit will consist of consent and health history forms, 
measurements, and a familiarization session on the muscle testing 
machine.  All individuals will be measured in the BodPod to obtain body fat 
percentages on the first and fourth visits and have their height measured 
on the first visit.   
  Over the next three visits, each individual will be asked to 
consume one of the following beverages: original RockStar, sugar-free 
RockStar, or a similarly flavored placebo until each beverage has been 
consumed.  Each individual will be asked to write down what he ate for 
dinner the night before and to complete a questionnaire asking how he 
feels at that moment.  He will then complete a muscle test to determine 
lower body strength and endurance.  Each visit will last 1-1.5 hours and 
111 
 
will be scheduled 2 weeks apart, which is the equivalent to every other 
week. 
 Your participation in this study is voluntary.  If you have any 
questions concerning the research study, please call me at (480) 727-
1967 or email me at mhawley3@asu.edu. 
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APPENDIX E  
PRE-SCREENING SURVEY 
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1. How many caffeinated beverages do you consume each day? 
 A. 0 B. 1-2 C. 3-4 D. 5+ 
2. Do you consume energy drinks on a regular basis? 
 A. Yes B. No 
3. Do you consume energy drinks before you workout? 
 A. Yes B. No 
4. Have you ever experienced any negative side effects from consuming energy 
drinks? 
 A. Yes B. No C. I have never consumed an energy drink 
5. Have you ever experienced any negative side effects from consuming any other 
caffeinated beverages? 
 A. Yes B. No  
6. Are you willing to limit your caffeine intake for a period of 8 weeks? 
 A. Yes B. No 
7. How many days per week do you participate in high intensity physical activity? 
(Interval training, circuits, bootcamps, etc.) 
 A. 1 B. 2 C. 3 D. 4 E. 5+ 
8. How many days per week do you participate in low intensity physical activity? 
(Weight lifting, jogging/walking, yoga) 
 A. 1 B. 2 C. 3 D. 4 E. 5+ 
9. Are you willing to limit your physical activity to 2-3 days per week?  
(Excluding walking the dog, household duties, etc.) 
 A. Yes B. No 
10. Will you be traveling during the months of July, August, or September? 
 A. Yes B. No 
11. If you will be traveling, how long will you be out of town? 
 A. 1 week B. 2 weeks C. 3 weeks D. 4+ weeks 
12. Should you be eligible for this study, are you willing to come to the ASU 
Polytechnic campus between the hours of 8am and 10am in a fasted (no food for 8 
hours) state? 
 A. Yes B. No 
13. Should you be eligible for this study, are you willing to come to the ASU 
Polytechnic campus on four different occasions for 1-2 hours per visit? 
 A. Yes B. No 
14. Are you interested in participating in a study evaluating the effectiveness of 
RockStar energy drink on muscular strength? 
 A. Yes B. No 
15. Are you interested in finding out what your percent body fat and muscular 
strength measures are? 
 A. Yes B. No 
16. Do you want to be contacted if you are eligible for participation in this study? 
 A. Yes B. No 
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APPENDIX F  
NIH CERTIFICATION 
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APPENDIX G  
MEDICAL AND HEALTH HISTORY QUESTIONNAIRE 
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SUBJECT ID #________  Today’s Date:                     
 Age:    
 
MEDICAL & HEALTH HISTORY QUESTIONNAIRE  
 
Please answer all questions to the best of your knowledge. 
 
1. Blood pressure 
    Do you have high blood pressure?      Yes    
No 
    Have you had high blood pressure in the past?    Yes    
No 
    Are you on medication for high blood pressure?    Yes    
No 
 
2. Cholesterol 
    Do you have high cholesterol?      Yes    
No 
    Are you on cholesterol-lowering medication?    Yes    
No 
 
3. Smoking 
    Do you smoke?        Yes    
No 
    Are you a former smoker?       Yes    
No 
        If yes, please give the date you quit.       
 
4. Diabetes 
    Do you have diabetes?       Yes    
No 
 
5. Heart problems 
    Have you ever had a heart attack?      Yes    
No 
    Have you ever had heart surgery?      Yes    
No 
    Have you ever had angina (pain in your chest)?    Yes    
No 
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6. Have you ever experienced nausea, dizziness, or felt light-headed:  
    During physical activity?       Yes    
No  
    After physical activity?       Yes    
No 
    
7. Family history 
    Have any of your blood relatives had heart disease, heart surgery, or  
    angina?         Yes    
No 
 
8. Orthopedic problems 
    Do you have any serious orthopedic problems that would prevent you 
    from exercising?        Yes    
No 
        If yes, please explain 
                    
                    
                    
 
 
 
 
9. Other problems 
    Do you have any reason to believe you should not exercise?  Yes    
No 
        If yes, please explain 
                    
                    
                     
 
10. Please list ALL medications that you are currently taking: 
      _______________________________________________________________ 
      _______________________________________________________________
  
      _______________________________________________________________ 
 
 
11. Please list ANY supplements/vitamins that you are currently taking: 
      _______________________________________________________________ 
      _______________________________________________________________
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APPENDIX H  
BEVERAGE CONSUMPTION SURVEY 
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APPENDIX I  
PREVIOUS NIGHT’S DINNER RECORD 
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Subject I.D. ___________ 
    
Record of Previous Night’s Dinner 
 
Date:________     Time of Meal:_______ 
What did you eat for dinner last night? 
 
 
 
 
Date:________     Time of Meal:_______ 
What did you eat for dinner last night? 
 
 
 
 
Date:________     Time of Meal:_______ 
What did you eat for dinner last night? 
 
 
 
 
Date:________     Time of Meal:_______ 
What did you eat for dinner last night? 
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APPENDIX J  
PROFILE OF MOOD STATES QUESTIONNAIRE 
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APPENDIX K  
DETAILED INSTRUCTIONS FOR THE ISOKINETIC DYNAMOMETER 
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Protocol for Humac Norm Isokinetic Dynamometer 
Seated Knee Extension and Flexion Series 
 Dynamometer Set Up 
(Specific to left knee) 
Move the first dynamometer stop to position G on the black scale and the second 
stop to position M on the green scale. 
Collect all of the adapters and stabilizers for the knee extension tests. 
 You will need: the knee stroke hip pad, the knee-hip adapter, the contra-
lateral limb stabilizer,  
 and the lumbar cushion (optional).   
Adjust the chair rotation by lifting the locking handles and rotating the chair to 40 
degrees on the black scale.  Push down both handles to secure locks. 
Set the chair back angle by lifting the locking handles and adjusting the angle to 
85 degrees.  Push down both handles to secure locks. 
Change the chair fore aft by raising the handles and sliding the chair forward or 
backward to position 15.  Lower the handles into the locked position to secure. 
Set the chair back translation by winding the handle and adjusting to position 15. 
Set the seat to the “up” position by lifting and releasing the lever on the side of 
the seat. 
Set the dynamometer tilt by releasing the locking handles and adjusting the tilt to 
0 degrees.  Tighten the handles to secure. 
The dynamometer rotation and height are adjusted together by lifting the locking 
handles and rotating the dynamometer to 40 degrees on the black scale and to 
lifting to position 8.  Press down on handles to lock. 
Position the monorail by pressing down on the kick board and sliding the chair to 
position 27.   
Install the knee-hip adapter by placing it into the adapter arm and tightening the 
lock.  Press the retaining button on the knee-hip adapter arm and slide the pad into 
position, choosing either the long end or the short end depending on tibial offset.   
Insert the contra-lateral limb stabilizer into the “2” arm so the stabilizer is facing 
the limb not being tested.  Pull the locking pin out to adjust the tightness and 
height of the stabilizer.    
 
Subject Set Up 
Now ask the subject to sit on the chair.   
Adjust the chair back translation so it is appropriate for the subject.  Move it until 
there is a gap between the seat and the calf muscle.  A two finger gap is sufficient. 
Place the limb not being tested behind the contra-lateral limb stabilizer pad. 
Attach the thigh strap to the limb being tested and pull the strap until the 
appropriate tension is attained. 
Place the subject’s arms through each of the vertical chair strap loops and use the 
clasp to connect the straps together.  Tighten the straps until the waist strap is just 
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above belt level.  Now tighten the waist strap until at a comfortable tension while 
keeping the clasp on the midline of the waist.   
Adjust the monorail so the shin will rest against the center of the calf pad.   
Set the axis of rotation so that the axis of the knee joint (lateral femoral 
epicondyle) is directly in line with the black dot on the dynamometer arm.  The 
chair fore aft and the dynamometer height may need to be adjusted.   
Ask the subject to maximally dorsiflex their foot and adjust the calf pad until it is 
placed just above the top of the foot.  Secure the pad by using the strap.  Manually 
extend and flex the knee to check the positioning of the calf pad.  If the pad rubs 
up and down the shin, the axis of rotation needs to be readjusted.   
Encourage the subject to hold onto the lateral seat handles during testing to 
maximize results.     
 
Set Anatomical Zero 
Extend the limb, click “OK” 
Keep limb extended and click “EXT”.  This sets the maximal extension height. 
Click on the box next to “Track Patient ROM” and flex the limb.  This sets the 
total range of motion and will attain settings specific to this client.  The settings 
will be given in two alphabetical letters.  Once these letters are obtained, the limb 
can be moved into a neutral, or relaxed, position. 
Move the mechanical stops to set them to the correct settings.   
 
Weigh Limb 
Extend the limb, click on the box next to “Raise Limb to Max Comfortable 
Height”. 
Click on the box next to “Allow to Begin Falling”.  Ask the subject to clasp their 
hands together such that one palm is facing towards their chest and the other is 
facing away while their fingers are bent into the shape of a “C” and hooked 
together.  Ask the subject to try to pull their hands apart and close their eyes while 
letting their limb fall naturally.   
Click on the box next to “Wait for MaxGET to Appear”.  Once a value has been 
obtained for the weight of the limb, click on the box next to “OK”. 
This is the gravity corrected weight for the limb being tested and will be taken 
into consideration for error correction during the testing. 
 
Five Repetition Warm-Up 
The subject will complete 5 repetitions at a speed of 180 degrees per second. 
This warm-up will prepare the subject for the three peak torque tests and the 
fatigue test to follow. 
 
Isokinetic Knee Extension Testing 
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The subject will complete 2 practice repetitions and 1 test repetition at each 
speed: 240, 180, and 60 degrees per second to obtain peak torque values.   
The subject will then complete 50 repetitions at a speed of 240 degrees per second 
to obtain a fatigue index.   
These tests will be completed all the way through for one leg and then the 
machine will be adjusted and set up to complete the warm-up and tests for the 
opposite leg. 
All tests will be done according to manufacturer instructions and 
recommendations.   
Only instructions will be given throughout testing; no encouragement will be 
given during any testing. 
 
Tests and Cues: 
Ask the subject to flex his knee all the way back as far as he can and to keep it 
there to begin the test. 
Now instruct the subject to maximally extend his leg two times and then to relax. 
There is a thirty second rest period.  When there are two seconds left before the 
time expires, ask the subject to fully flex his knee.  Once time expires, instruct 
him to maximally extend his leg one time and then to relax. 
There is a thirty second rest period and the machine will move on to the next 
speed to be tested.  At the twenty-eight second mark, ask the subject to fully flex 
his knee.  Once time expires, instruct him to maximally extend his leg two times 
and then to relax. 
There is a thirty second rest period.  When there are two seconds left in the 
period, ask the subject to fully flex his knee.  Once time expires, ask him to 
maximally extend his leg one time and then to relax. 
There is a thirty second rest period and the machine will move on to the third 
speed to be tested.  At the twenty-eight second mark, ask the subject to fully flex 
his knee.  Once time expires, instruct him to maximally extend his leg two times 
and then to relax. 
There is a thirty second rest period.  Where there are two seconds left in the 
period, ask the subject to fully flex his knee.  Once time expires, instruct him to 
maximally extend his leg one time and then to relax. 
There is a thirty second rest period and the machine will move on to the fatigue 
test to be done at a speed of 240 degrees per second.  At the twenty-eight second 
mark, instruct the subject to fully flex his knee.  Once time expires, instruct him to 
maximally extend and flex his knee fifty times to exhaustion.   
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APPENDIX L  
RANDOMIZATION CHART 
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Subjec
t ID 
Visit 
2 
Visit 
3 
Visit 
4   Order of Speeds 
RS 1 C B A 
LR 
180,240,60 
RL 
60,180,240 
LR 
240,180,60 
RS 2 B A C 
RL 
60,240,180 
LR 
180,240,60 
RL 
180,60,240 
RS 3 C B A 
LR 
240,180,60 
RL 
60,180,240 
LR 
240,180,60 
RS 4 B C A 
RL 
180,60,240 
LR 
60,240,180 
RL 
180,240,60 
RS 5 A C B 
LR 
180,240,60 
RL 
180,60,240 
LR 
60,240,180 
RS 6 C A B 
RL 
180,240,60 
LR 
60,240,180 
RL 
240,60,180 
RS 7 A B C 
LR 
60,240,180 
RL 
60,180,240 
LR 
60,180,240 
RS 8 B C A 
RL 
240,60,180 
LR 
60,240,180 
RL 
180,240,60 
RS 9 A B C 
LR 
180,60,240 
RL 
180,60,240 
LR 
60,180,240 
RS 10 B C A 
RL 
180,240,60 
LR 
60,180,240 
RL 
180,240,60 
RS 11 A C B 
LR 
60,180,240 
RL 
180,240,60 
LR 
60,240,180 
RS 12 C B A 
RL 
180,60,240 
LR 
180,60,240 
RL 
240,180,60 
RS 13 C A B 
LR 
60,240,180 
RL 
240,180,60 
LR 
240,60,180 
RS 14 C B A 
RL 
60,180,240 
LR 
60,240,180 
RL 
240,180,60 
RS 15 B C A 
LR 
60,240,180 
RL 
180,240,60 
LR 
180,240,60 
RS 16 C B A 
RL 
180,60,240 
LR 
180,240,60 
RL 
240,180,60 
RS 17 A B C 
LR 
60,240,180 
RL 
180,60,240 
LR 
60,180,240 
RS 18 B A C 
RL 
60,180,240 
LR 
240,180,60 
RL 
180,60,240 
RS 19 C B A 
LR 
180,240,60 
RL 
240,180,60 
LR 
60,240,180 
RS 20 C A B 
RL 
60,180,240 
LR 
180,240,60 
RL 
240,60,180 
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*Code for each cup: Subject ID Ex: RS 1 
   
  
Treatment # T1 
      Treatment Letter A 
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APPENDIX M 
SUBJECT INFO SHEET VISITS 1 AND 2 
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Subject I.D.:    
BodPod 
1:       
Date (1):   
Height 
(cm):        
Date (2):   
60 
deg/sec 
180 
deg/sec 
240 
deg/sec 50 reps 
Treatment V2           
P.T.- Right 
Extensor           
P.T.- Right 
Flexor           
P.T.- Left 
Extensor           
P.T.- Left Flexor           
T.W.- Right 
Extensor           
T.W.- Right 
Flexor           
T.W.- Left 
Extensor           
T.W.- Left Flexor           
F.I.- Right 
Extensor           
F.I.- Right Flexor           
F.I.- Left 
Extensor           
F.I.- Left Flexor           
      PT= Peak 
Torque 
     TW= Total Work in Foot-Pounds 
   FI= Fatigue 
Index 
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APPENDIX N  
SUBJECT INFO SHEET VISIT 3 
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Subject I.D.:    Height:       
Date:   
60 
deg/sec 
180 
deg/sec 
240 
deg/sec 50 reps 
Treatment           
P.T.- Right 
Extensor           
P.T.- Right 
Flexor           
P.T.- Left 
Extensor           
P.T.- Left Flexor           
T.W.- Right 
Extensor           
T.W.- Right 
Flexor           
T.W.- Left 
Extensor           
T.W.- Left Flexor           
F.I.- Right 
Extensor           
F.I.- Right Flexor           
F.I.- Left 
Extensor           
F.I.- Left Flexor           
      PT= Peak 
Torque 
     TW= Total Work in Foot-Pounds 
   FI= Fatigue 
Index 
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APPENDIX O  
SUBJECT INFO SHEET VISIT 4 
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Subject I.D.:    Height:   
Bod Pod 
%   
Date:   
60 
deg/sec 
180 
deg/sec 
240 
deg/sec 50 reps 
Treatment           
P.T.- Right 
Extensor           
P.T.- Right 
Flexor           
P.T.- Left 
Extensor           
P.T.- Left Flexor           
T.W.- Right 
Extensor           
T.W.- Right 
Flexor           
T.W.- Left 
Extensor           
T.W.- Left 
Flexor           
F.I.- Right 
Extensor           
F.I.- Right 
Flexor           
F.I.- Left 
Extensor           
F.I.- Left Flexor           
      PT= Peak 
Torque 
     TW= Total Work in Foot-Pounds 
   FI= Fatigue 
Index 
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APPENDIX P 
TABLE 1 A AND B 
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 (A) Ingredients in RockStar (Original)   
Ingredient      Amount Per 8 oz Serving % Daily Value 
Calories 
  
140    
Total Carbohydrates 
 
31g 10%  
   Sugars 
  
31g *  
Vitamin B2 
 
3.4mg 200%  
Vitamin B3 
 
20mg 100%  
Vitamin B5 
 
10mg 100%  
Vitamin B6 
 
2mg 100%  
Vitamin B12 
 
6mcg 100%  
Sodium 
  
125mg 5%  
Energy Blend   1.35g *  
Taurine 
 
  1000mg *  
Ginkgo Biloba Leaf Extract 150mg *  
Caffeine 
 
  80mg *  
Guarana Seed Extract 25mg *  
Inositol 
  
25mg *  
L-Carnitine 
 
25mg *  
Panax Ginseng Extract 25mg *  
Milk Thistle Extract   20mg *  
 
(B)  Ingredients in Sugar Free RockStar   
Ingredient 
  
Amount Per 8 oz Serving % Daily Value 
Calories 
  
10    
Total Carbohydrates 
 
0g 0%  
Sugars 
  
0g *  
Vitamin B2 
 
3.4mg 200%  
Vitamin B3 
 
20mg 100%  
Vitamin B5 
 
10mg 100%  
Vitamin B6 
 
2mg 100%  
Vitamin B12 
 
6mcg 100%  
Sodium 
  
125mg 5%  
Energy Blend   1.35g *  
Taurine 
 
  1000mg *  
Ginkgo Biloba Leaf Extract 150mg *  
Caffeine 
 
  80mg *  
Guarana Seed Extract 25mg *  
Inositol 
  
25mg *  
L-Carnitine 
 
25mg *  
Panax Ginseng Extract 25mg *  
Milk Thistle Extract   20mg *  
* % Daily Value is unknown 
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APPENDIX Q 
PLACEBO INGREDIENTS 
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Sugar Free, Caffeine Free Placebo   
Serving Size 16 fluid ounces     
Sierra Mist Free 
  
450 ml 
Crystal Light Natural Cherry Pomegranate 0.75 tsp 
Lime Juice 
  
1 tsp 
Citric Acid     1 tsp 
142 
 
APPENDIX Q 
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